Introduction {#s1}
============

Growth of photosynthetic organisms depends on light energy, which in turn can cause oxidative damage to the cell if not managed properly ([@bib39]). Light intensity is highly dynamic in terrestrial and aquatic environments, and the cell must constantly control the dissipation of light energy to avoid photo-oxidative stress while maximizing productivity. In addition to being the site of photosynthesis, the chloroplast houses many essential biochemical reactions such as fatty acid and amino acid biosynthesis, but most of its proteins are encoded in the nucleus and must be imported after translation. Therefore the nucleus must monitor the status of the chloroplast and coordinate gene expression and synthesis of proteins to maintain healthy chloroplast functions.

It is known that signals originating from a stressed or dysfunctional chloroplast modulate nuclear gene expression, a process that is called retrograde signaling ([@bib50]; [@bib12]). In *Arabidopsis thaliana* the *gun* mutants have helped to define the field of chloroplast retrograde signaling, leading to the identification of GUN1, a pentatricopeptide repeat protein that is a regulator of this process ([@bib32]), and pointing to the involvement of the tetrapyrrole biosynthetic pathway ([@bib69]; [@bib45]; [@bib34]; [@bib61]; [@bib76]). A role for heme in retrograde signaling has been shown in *Chlamydomonas reinhardtii* as well ([@bib70]). Many of the *gun* studies were conducted in context of a dysfunctional chloroplast treated with norflurazon, an inhibitor of carotenoid biosynthesis. More recently a number of exciting advances have shed light on small molecules playing roles in retrograde stress signaling, including methylerythritol cyclodiphosphate, an intermediate of isoprenoid biosynthesis in the chloroplast ([@bib77]), 3-phosphoadenosine 5-phosphate (PAP) ([@bib19]), as well as a chloroplast envelope transcription factor PTM ([@bib62]). Plastid gene expression involving sigma factors has been implicated in affecting nuclear gene expression, although the mechanism is unknown ([@bib13]; [@bib75]).

Activation of gene expression by reactive oxygen species (ROS) has been well documented ([@bib4]; [@bib44]; [@bib23]; [@bib39]). Thus ROS have been proposed as a means for chloroplasts to signal stress to the nucleus and many examples of global gene expression changes in response to ROS have been described ([@bib16]; [@bib67]; [@bib68]). Singlet oxygen (^1^O~2~) is a highly toxic form of ROS that can be formed in all aerobic organisms through photosensitization reactions in which excitation energy is transferred from a pigment molecule to O~2~. For example, porphyria in humans is caused by defects in tetrapyrrole metabolism that can lead to accumulation of photosensitizing intermediates, which generate ^1^O~2~ in the light ([@bib60]). In oxygenic photosynthetic organisms, ^1^O~2~ is mainly generated at the reaction center of photosystem II, when triplet excited chlorophyll transfers energy to O~2~ ([@bib33]). ^1^O~2~ is the predominant cause of lipid oxidation during photo-oxidative stress ([@bib65]) and is associated with damage to the reaction center ([@bib64]). Because of the abundance and proximity of the two elements of ^1^O~2~ generation, the photosensitizer chlorophyll and O~2~, it was hypothesized that oxygenic photosynthetic organisms must have evolved robust means to cope with this ROS ([@bib31]). In *Arabidopsis*, the EX1 and EX2 proteins in the chloroplast are required for the execution of a ^1^O~2~-dependent response: growth arrest in plants and programmed cell death in seedlings, that is distinct from cell damage ([@bib51]; [@bib71]; [@bib37]). Different players in ^1^O~2~ signaling have emerged recently, such as β-cyclocitral, an oxidation product of β-carotene in *Arabidopsis* ([@bib53]), a bZIP transcription factor (SOR1) responding to reactive electrophiles generated by ^1^O~2~ ([@bib21]), and a cytosolic zinc finger protein conserved in *Arabidopsis* and *Chlamydomonas,* MBS ([@bib56]). In the anoxygenic photosynthetic bacterium *Rhodobacter sphaeroides*, a σ^E^ factor is responsible for the elicitation of the gene expression response to ^1^O~2~ ([@bib3]).

The unicellular green alga *Chlamydomonas reinhardtii* is an excellent model organism for investigation of retrograde ^1^O~2~ signaling. *Chlamydomonas* exhibits an acclimation response to ^1^O~2~, in which exposure to a sublethal dose of ^1^O~2~ leads to changes in nuclear gene expression that enable cells to resist a subsequent challenge with higher levels of ^1^O~2~ ([@bib35]). We hypothesized that acclimation mutants should include regulatory mutants that are defective in sensing and responding to ^1^O~2~. Here we describe the isolation of such a mutant and identification of a cytosolic phosphoprotein SAK1 that is critical for the acclimation and transcriptome response to ^1^O~2~.

Results {#s2}
=======

Isolation of a singlet oxygen-sensitive mutant that is defective in acclimation {#s2-1}
-------------------------------------------------------------------------------

*Chlamydomonas* acclimates to singlet oxygen (^1^O~2~) generated by the exogenous photosensitizing dye rose bengal (RB) in the light ([@bib35]). As shown in [Figure 1A](#fig1){ref-type="fig"}, wild-type (WT) cells that were pretreated with RB in the light were able to survive a challenge treatment with much higher concentrations of RB, unlike cells pretreated with RB in the dark. By screening an insertional mutant population ([@bib15]) for strains that were sensitive to ^1^O~2~, we isolated a mutant called *[s]{.ul}inglet oxygen [a]{.ul}cclimation [k]{.ul}nocked-out1* (*sak1*) that is defective in acclimation to ^1^O~2~ ([Figure 1A](#fig1){ref-type="fig"}). We have previously shown that *Chlamydomonas* WT cells can also acclimate to RB following pretreatment with high light ([@bib35]), indicating that high light and RB induce overlapping responses to ^1^O~2~. When subjected to the same conditions (high light pretreatment followed by challenge with RB), *sak1* demonstrated less robust cross-acclimation ([Figure 1B](#fig1){ref-type="fig"}). We also tested conversely whether pretreatment with RB can acclimate the cells to growth in high light or in the presence of norflurazon. No increase in resistance to high light or norflurazon was induced by pretreatment with RB in either WT or *sak1* ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). The viability phenotypes after RB treatment shown in [Figure 1A](#fig1){ref-type="fig"} were paralleled by changes in F~v~/F~m~ values, a chlorophyll fluorescence parameter representing photosystem II efficiency ([Figure 1C](#fig1){ref-type="fig"}). In both WT and *sak1,* pretreatment did not cause an inhibition of photosystem II, as demonstrated by unchanged F~v~/F~m~ values after 30 min. However, pretreatment increased resistance of photosystem II to the RB challenge only in WT and not in *sak1* cells ([Figure 1C](#fig1){ref-type="fig"}). The pretreatment protected the cells only transiently, as by 90 min of challenge treatment both genotypes appeared to have experienced similar inhibition of photosystem II ([Figure 1C](#fig1){ref-type="fig"}), consistent with the hypothesis that *sak1* is disrupted in early sensing and/or initiation of ^1^O~2~ response rather than its direct detoxification.10.7554/eLife.02286.003Figure 1.The *sak1* mutant is defective in singlet oxygen acclimation.(**A**) Acclimation phenotype of WT and *sak1*. The cells were pretreated in the dark (−) or under light (+) in the presence of rose bengal (RB), which requires light for generation of ^1^O~2~. Pretreatment was followed by a subsequent higher concentration of RB (Challenge) as indicated under light. (**B**) Cells grown in low light were either kept in low light (−) or transferred to high light (+) for an hour before challenge in the light with increasing RB concentrations. (**C**) F~v~/F~m~ values were measured after each time point indicated. Pretreatment (PreT) with 0.5 μM RB was applied for 30 min with (+PreT) or without (−PreT) light. After the pretreatment, RB was added to both dark and light samples to a final concentration of 3.75 μM RB (challenge), and F~v~/F~m~ was measured for 90 min at 30 min intervals (total 120 min). First arrow: addition of pretreatment; second arrow: addition of challenge. (**D**) *sak1* has wild-type sensitivity to other photo-oxidative stresses. Serial dilutions of WT and *sak1* were spotted onto minimal (HS) plates at the indicated light intensity or on TAP plates containing the indicated inhibitor. DCMU, 3-(3,4-dichlorophenyl)-1,1-dimethylurea; low light (LL), 80 µmol photons m^−2^ s^−1^; high light (HL), 450 µmol photons m^−2^ s^−1^. (**E**) Gene expression of a known ^1^O~2~-responsive gene, *GPX5,* is induced during acclimation, while two genes associated with H~2~O~2~ response, *APX1* and *CAT1,* are not. WT cells were mock-pretreated without RB (white bars) or pretreated with RB in the light (black bars).**DOI:** [http://dx.doi.org/10.7554/eLife.02286.003](10.7554/eLife.02286.003)10.7554/eLife.02286.004Figure 1---figure supplement 1.Pretreatment with RB does not increase resistance to high light or norflurazon in cells grown on plates.Cells were pretreated with 1 μM RB with (+) or without (−) light, then spotted on minimal plates and grown under high light (HL) or grown photoheterotrophically on TAP plates containing norflurazon (NF) and grown under low light for 4 days. Cells were spotted in serial dilutions.**DOI:** [http://dx.doi.org/10.7554/eLife.02286.004](10.7554/eLife.02286.004)

In contrast to its RB sensitivity, *sak1* exhibited wild-type resistance to high light, various photosynthetic inhibitors and generators of other ROS, suggesting its defect is specific to ^1^O~2~ ([Figure 1D](#fig1){ref-type="fig"}). When tested for the gene expression response of the known ^1^O~2~-specific gene *GPX5* ([@bib38]) during acclimation, WT cells showed a 20- to 30-fold induction, whereas a known H~2~O~2~-responsive ascorbate peroxidase gene (*APX1*) in *Chlamydomonas* ([@bib66]) and a catalase gene (*CAT1*), known to be H~2~O~2~ responsive in *Arabidopsis* ([@bib14]; [@bib68]), were unchanged. The mutant *sak1* showed attenuated *GPX5* induction, as expected for a mutant defective in the ^1^O~2~ response ([Figure 1E](#fig1){ref-type="fig"}).

The global gene expression response to ^1^O~2~ in *Chlamydomonas* is distinct from that in *Arabidopsis* {#s2-2}
--------------------------------------------------------------------------------------------------------

To obtain insight into the cellular processes and the genes involved in ^1^O~2~ acclimation, we used RNA-seq to define the transcriptome of WT cells during acclimation. The sequences were mapped to the *Chlamydomonas reinhardtii* genome version 4 (v4), and 16476 transcripts corresponding to gene models were detected ([@bib72]). We validated the data by quantitative reverse transcriptase PCR (qRT-PCR) for some of the differentially expressed genes during acclimation ([Figure 2](#fig2){ref-type="fig"}). Basal expression of some of the genes was elevated in *sak1* compared to WT (Cre16.g683400 and *GST1,* [Figure 2](#fig2){ref-type="fig"}). Comparisons of the fold change (FC) values obtained by RNA-seq and qRT-PCR for the genes tested in [Figure 2](#fig2){ref-type="fig"} are shown in [Figure 2](#fig2){ref-type="fig"}. The FC values are comparable between the two methods, although genes with FC greater than 20 (detected by RNA-seq) showed FC values (estimated by qRT-PCR) that were two to three times higher (Cre06.g281250.t1.1, Cre13.g566850.t1.1, Cre06.g263550.t1.1, Cre14.g623650.t1.2). Some of the genes were also induced by a transition from low light to high light, although not as strongly ([Table 1](#tbl1){ref-type="table"}), indicating that the ^1^O~2~ response elicited by addition of RB partly overlaps with that caused by increased light intensity. To examine whether the transcriptome changes were specific to ^1^O~2~, we examined the expression of several previously identified H~2~O~2~-responsive genes ([@bib66]) ([Table 2](#tbl2){ref-type="table"}). Two of the seven genes, *VTC2* (3.4-fold) and *DHAR1* (twofold) were induced during ^1^O~2~ acclimation, whereas the other five genes were not differentially expressed (induced more than twofold) in our data. For these two genes, their magnitude of induction by ^1^O~2~ was smaller than that of H~2~O~2~-treated cells (both genes were ∼ninefold induced by 1 mM H~2~O~2~ treatment for 60 min) ([@bib66]). These differences suggest that our treatment with ^1^O~2~ did not lead to a large-scale induction of H~2~O~2~-responsive genes, and it is likely that the two above-mentioned genes involved in ascorbate metabolism respond to both H~2~O~2~ and ^1^O~2~.10.7554/eLife.02286.005Figure 2.qRT-PCR analysis of genes identified to be ^1^O~2~-responsive by RNA-seq.(**A**) The error bars indicate standard deviation of biological triplicates. The locus of the transcript (v5) and gene name if annotated, are indicated. \*SOUL1 was named gene in v4 but not in v5. (**B**) Comparison of fold change values from RNA-seq data and qPCR. Fold change values were calculated for RNA-seq as described in 'Material and methods', and the values for qPCR are averages obtained from biological triplicates.**DOI:** [http://dx.doi.org/10.7554/eLife.02286.005](10.7554/eLife.02286.005)10.7554/eLife.02286.006Table 1.Moderate induction of ^1^O~2~ genes during high light exposure**DOI:** [http://dx.doi.org/10.7554/eLife.02286.006](10.7554/eLife.02286.006)Fold change (SD)[\*](#tblfn1){ref-type="table-fn"}Gene name or IDWT*sak1GPX5*2.86 (1.06)1.08 (0.23)*CFA1*3.75 (0.99)1.78 (0.52)*SOUL2*3.45 (1.25)1.82 (0.22)*MRP3*3.10 (0.39)2.37 (0.32)Cre14.g6139501.42 (0.53)1.57 (0.46)*LHCSR1*[†](#tblfn2){ref-type="table-fn"}14.91 (4.25)2.91 (1.35)[^5][^6]10.7554/eLife.02286.007Table 2.Expression of H~2~O~2~ response genes during ^1^O~2~ acclimation**DOI:** [http://dx.doi.org/10.7554/eLife.02286.007](10.7554/eLife.02286.007)Gene IDRPKM[\*](#tblfn3){ref-type="table-fn"}Fold change[†](#tblfn4){ref-type="table-fn"}Gene namev4v5WT-mockWT-RB*sak1*-mock*sak1*-RBWT*sak1APX1*Cre02.g087700.t1.1Cre02.g087700.t1.249.7036.2279.6558.830.730.74*MSD3*Cre16.g676150.t1.1Cre16.g676150.t1.20.300.180.700.170.600.25*MDAR1*Cre17.g712100.t1.1Cre17.g712100.t1.235.9538.3033.5351.341.071.53*DHAR1*Cre10.g456750.t1.1Cre10.g456750.t1.220.4040.9325.6942.182.011.64*GSH1*Cre02.g077100.t1.1Cre02.g077100.t1.228.2726.9140.4249.950.951.24*GSHR1*Cre06.g262100.t1.2Cre06.g262100.t1.319.1719.0219.3922.410.991.16*VTC2*Cre13.g588150.t1.1Cre13.g588150.t1.218.1662.5335.10103.123.442.94[^7][^8]

During acclimation of WT to ^1^O~2~, 515 genes were up-regulated at least twofold with a false discovery rate (FDR) smaller than 1% ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}, C1), and 33% of these could be categorized into functional classes based on MapMan ([@bib63]) using the Algal Functional Annotation Tool ([@bib42]) ([Figure 3A,B](#fig3){ref-type="fig"}). The enriched classes are marked with asterisks, and the genes within those classes are listed in [Table 3](#tbl3){ref-type="table"}. Genes involved in sterol/squalene/brassinosteroid metabolism (in the hormone and lipid metabolism functional classes) were notably enriched ([Table 3](#tbl3){ref-type="table"}). A sterol methyltransferase was also detected to display differential expression in our previous microarray analysis ([@bib35]). Brassinosteroids are not known to exist in *Chlamydomonas*, and in plants increasing evidence indicates sterols have a signaling role independent of brassinosteroids ([@bib39a]; [@bib9]). Two cyclopropane fatty acid synthases (CFAs) were among the up-regulated lipid metabolism genes ([Table 3](#tbl3){ref-type="table"}). Another function that was notable among up-regulated genes, although they were not grouped to a common functional class by MapMan, were two genes coding for SOUL heme-binding domain proteins that were *SAK1*-dependent (SOUL2 and Cre06.g299700.t1.1, formerly annotated as SOUL1) ([Figure 2](#fig2){ref-type="fig"}). Genes annotated as involved in transport comprised one of the most enriched classes ([Figure 3B](#fig3){ref-type="fig"}). These included a number of multidrug-resistant (MDR) and pleiotropic drug-resistant (PDR) type transporters as well as other various transporters for ions, peptides, and lipids ([Table 3](#tbl3){ref-type="table"}). The former types of transporters may reflect the cells\' response to pump RB out. When the responses to the chemical RB and ^1^O~2~ were uncoupled by comparing gene expression in cultures kept in the dark with and without RB, all of the tested ^1^O~2~-induced genes and ABC transporters identified from our RNA-seq remained unchanged by RB in the dark in both WT and *sak1* ([Table 4](#tbl4){ref-type="table"}). This result indicates that the up-regulation of these genes when RB was added in the light was a response to ^1^O~2~ rather than to RB itself. Up-regulation of stress genes included those coding for chaperones and some receptor-like proteins ([Figure 3B](#fig3){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}), suggesting that the cells do mount a stress response during acclimation though not visible by gross growth phenotype ([Figure 1A](#fig1){ref-type="fig"}) or decrease in F~v~/F~m~ ([Figure 1C](#fig1){ref-type="fig"}). A smaller number of 219 genes was down-regulated during acclimation in WT ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}, C1), only 21% of which had functional annotation. The most enriched classes of down-regulated genes were nucleotide metabolism and transport, the latter including a distinct type of transporter for small metabolites and ions, different from those found among up-regulated genes that included many MDR- and PDR-type transporters ([Figure 3B](#fig3){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}).10.7554/eLife.02286.008Figure 3.Differentially expressed genes from pair-wise comparisons.(**A**) Venn diagram representing differentially expressed genes in WT and *sak1.* Mapman functional classes distribution of differentially expressed genes (passing criteria of fold change greater than 2^1^ \[up\] or smaller than 2^−1^ \[down\] with FDR \<1%) during acclimation in (**B**) WT and (**C**) *sak1.* (**D**) Differentially expressed genes when comparing WT and *sak1* in basal conditions (i.e., before exposure to ^1^O~2~). The functional classes represented by the numbers are listed; asterisks indicate classes that were enriched compared to the genome.**DOI:** [http://dx.doi.org/10.7554/eLife.02286.008](10.7554/eLife.02286.008)10.7554/eLife.02286.009Table 3.Enriched functional classes among differentially expressed genes in WT during ^1^O~2~ acclimation**DOI:** [http://dx.doi.org/10.7554/eLife.02286.009](10.7554/eLife.02286.009)Primary MapMan classSecondary Mapman classGene ID (v4)Gene ID (v5)Gene nameAnnotationUp-regulated genes transportABC transporters and multidrug resistance systemsCre03.g169300.t1.1Cre03.g169300.t2.1ABC transporter (ABC-2 type)Cre04.g220850.t1.1Cre04.g220850.t1.2ABC transporter (ABC-2 type)Cre11.g474600.t1.1[§](#tblfn8){ref-type="table-fn"}Cre02.g095151.t1ABC transporter (ABC-2 type)Cre03.g151400.t1.2Cre03.g151400.t1.3ABC transporter (subfamilyA member3)Cre14.g618400.t1.1[§](#tblfn8){ref-type="table-fn"}Cre14.g618400.t1.2ABC transporterCre09.g395750.t1.2Cre09.g395750.t1.3ABC transporter (plant PDR pleitropic drug resistance)Cre14.g613950.t1.1[§](#tblfn8){ref-type="table-fn"}Cre14.g613950.t2.1ABC transporter, Lipid exporter ABCA1 and related proteinsCre17.g725150.t1.1Cre17.g725150.t1.2ABC transporterCre04.g224400.t1.2[§](#tblfn8){ref-type="table-fn"}Cre04.g224400.t1.3ABC transporter (plant PDR pleitropic drug resistance)Cre13.g564900.t1.1[§](#tblfn8){ref-type="table-fn"}Cre13.g564900.t1.2*MRP3*ABC transporter, Multidrug resistance associated proteinCre17.g721000.t1.1Cre17.g721000.t1.2ABC transporter (ABCA)Cre04.g224500.t1.2Cre04.g224500.t1.3ABC transporter (plant PDR pleitropic drug resistance)Cre01.g007000.t1.1[§](#tblfn8){ref-type="table-fn"}Cre01.g007000.t1.2ABC transporter (ABC-2 type)unspecified anionsCre13.g574000.t1.2Cre13.g574000.t1.3Chloride channel 7Cre17.g729450.t1.1Cre17.g729450.t1.2Chloride channel 7amino acidsCre04.g226150.t1.2Cre04.g226150.t1.3*AOC1*Amino acid carrier 1; belongs to APC (amino acid polyamine organocation) familymiscCre16.g683400.t1.1[§](#tblfn8){ref-type="table-fn"}Cre16.g683400.t1.2CRAL/TRIO domain (Retinaldehyde binding protein-related)Cre17.g718100.t1.1Cre17.g718100.t1.2Phosphatidylinositol transfer protein SEC14 and related proteins (CRAL/TRIO)Cre06.g311000.t1.2Cre06.g311000.t1.3*FBT2*Folate transportecalciumCre09.g410050.t1.1[§](#tblfn8){ref-type="table-fn"}Cre09.g410050.t1.2Ca2+ transporting ATPasepotassiumCre07.g329882.t1.2Cre07.g329882.t1.3Ca2+-activated K+ channel proteinsphosphateCre16.g686750.t1.1Cre16.g686750.t1.2*PTA3*Proton/phosphate symportermetalCre13.g570600.t1.1Cre13.g570600.t1.2*CTR1*CTR type copper ion transportermetabolite transporters at the mitochondrial membraneCre06.g267800.t1.2Cre06.g267800.t2.1Mitochondrial carrier protein hormone metabolism[\*](#tblfn5){ref-type="table-fn"}brassinosteroidCre16.g663950.t1.1Cre16.g663950.t1.2Sterol C5-desaturaseCre02.g076800.t1.1Cre02.g076800.t1.2delta14-sterol reductaseCre12.g557900.t1.1Cre12.g557900.t1.1*CDI1*C-8,7 sterol isomeraseCre02.g092350.t1.1Cre02.g092350.t1.2Cytochrome P450, CYP51 Sterol-demethylaseCre12.g500500.t1.2Cre12.g500500.t2.1SAM-dependent methyltransferasesjasmonateCre19.g756100.t1.1Cre03.g210513.t112-oxophytodienoic acid reductaseauxinCre14.g609900.t1.1Cre14.g609900.t1.1Predicted membrane protein, contains DoH and Cytochrome b-561/ferric reductase transmembrane domainsCre06.g276050.t1.1Cre06.g276050.t1.2Aldo/keto reductaseCre16.g692800.t1.2Cre16.g692800.t1.3Aldo/keto reductaseCre03.g185850.t1.2Cre03.g185850.t1.2pfkB family, sugar kinase-related minor CHO metabolismothersCre06.g276050.t1.1Cre06.g276050.t1.2Aldo/keto reductaseCre16.g692800.t1.2Cre16.g692800.t1.3Aldo/keto reductaseCre03.g185850.t1.2Cre03.g185850.t1.2pfkB family, sugar kinase-relatedcalloseCre06.g302050.t1.1Cre06.g302050.t1.21,3-beta-glucan synthasemyo-inositolCre03.g180250.t1.1Cre03.g180250.t1.2Myo-inositol-1-phosphate synthase stressbioticCre01.g057050.t1.1[§](#tblfn8){ref-type="table-fn"}Cre03.g144324.t1Leucine Rich RepeatCre01.g016200.t1.2Cre01.g016200.t1Mlo FamilyCre28.g776450.t1.1[§](#tblfn8){ref-type="table-fn"}Cre08.g358573.t1*PSMD10*26S proteasome regulatory complexabioticCre12.g501500.t1.1NF[†](#tblfn6){ref-type="table-fn"}Cre02.g132300.t1.2Cre09.g395732.t1DnaJ domainCre07.g339650.t1.2Cre07.g339650.t1.3*DNJ20*DnaJ-like proteinCre01.g033300.t1.1[§](#tblfn8){ref-type="table-fn"}Cre01.g033300.t2.1No annotation[‡](#tblfn7){ref-type="table-fn"}Cre16.g677000.t1.1Cre16.g677000.t1.2*HSP70E*Heat shock protein 70ECre08.g372100.t1.1Cre08.g372100.t1.2*HSP70A*Heat shock protein 70A lipid metabolismphospholipid synthesisCre13.g604700.t1.2Cre13.g604700.t1.3*PCT1*CDP-alcohol phosphatidyltransferase/Phosphatidylglycerol-phosphate synthaseCre06.g281250.t1.1[§](#tblfn8){ref-type="table-fn"}Cre06.g281250.t1.2*CFA1*Cyclopropane fatty acid synthaseCre09.g398700.t1.1[§](#tblfn8){ref-type="table-fn"}Cre09.g398700.t1.2*CFA2*Cyclopropane fatty acid synthase'exoticsߣ (steroids, squalene etc)Cre01.g061750.t1.1Cre03.g146507.t1*SPT2*Serine palmitoyltransferaseCre83.g796250.t1.1NF[†](#tblfn6){ref-type="table-fn"}*SPT1*Serine palmitoyltransferaseCre02.g137850.t1.1Cre09.g400516.t1TRAM (translocating chain-associating membrane) superfamilyFA synthesis and FA elongationCre03.g182050.t1.1Cre03.g182050.t1Long-chain acyl-CoA synthetases (AMP-forming)Cre06.g256750.t1.1Cre06.g256750.t1.2Acyl-ACP thioesterasemiscshort chain dehydrogenase/reductase (SDR)Cre12.g556750.t1.2Cre12.g556750.t1.3Short chain dehydrogenaseCre27.g775000.t1.1Cre12.g549852.t1Short chain dehydrogenaseCre17.g731350.t1.2Cre17.g731350.t1.2Short chain dehydrogenaseCre08.g381510.t1.1[§](#tblfn8){ref-type="table-fn"}NF[†](#tblfn6){ref-type="table-fn"}Short chain alcohol dehydrogenaseUDP glucosyl and glucoronyl transferasesCre02.g144050.t1.1Cre02.g144050.t2.1Acetylglucosaminyltransferase EXT1/exostosin 1Cre16.g659450.t1.1Cre16.g659450.t1.2Lactosylceramide 4-alpha-GalactosyltransferaseCre03.g173300.t1.1Cre03.g173300.t1.2Lactosylceramide 4-alpha-GalactosyltransferasedynaminCre02.g079550.t1.1Cre02.g079550.t1.2Dynamin-related GTPase, involved in circadian rhythmsmisc2Cre06.g258600.t1.1[§](#tblfn8){ref-type="table-fn"}Cre06.g258600.t2.1Predicted hydrolase related to dienelactone hydrolaseacid and other phosphatasesCre06.g249800.t1.1Cre06.g249800.t1.2Sphingomyelin synthaseDown-regulated genes nucleotide metabolismsalvageCre13.g573800.t1.1Cre13.g573800.t1.2Phosphoribulokinase / Uridine kinase familysynthesisCre12.g503300.t1.1Cre12.g503300.t1.2Phosphoribosylamidoimidazole-succinocarboxamide synthaseCre06.g308500.t1.1Cre06.g308500.t1.2*CMP2*Carbamoyl phosphate synthase, small subunitCre14.g614300.t1.1Cre14.g614300.t1.2Inosine-5-monophosphate dehydrogenase transportABC transporters and multidrug resistance systemsCre06.g273750.t1.2Cre06.g273750.t1.3*SUA1*Chloroplast sulfate transporterCre02.g083354.t1.1Cre02.g083354.t1ATP-binding cassette, subfamily B (MDR/TAP), member 9calciumCre06.g263950.t1.2Cre06.g263950.t1.3Na+/K + ATPase, alpha subunitmetabolite transporters at the envelope membraneCre08.g363600.t1.1Cre08.g363600.t1.2Glucose-6-phosphate, PEP/phosphate antiportermetalCre17.g720400.t1.2Cre17.g720400.t1.3*HMA1*Heavy metal transporting ATPaseP- and V-ATPasesCre10.g459200.t1.1Cre10.g459200.t1.2*ACA4*Plasma membrane H + -transporting ATPasephosphateCre02.g144650.t1.1Cre02.g144650.t1.2*PTB12*Na+/Pi symporterpotassiumCre06.g278700.t1.2Cre06.g278700.t1.2Myotrophin and similar proteins[^9][^10][^11][^12]10.7554/eLife.02286.010Table 4.^1^O~2~ response genes are not induced when RB is added in the dark**DOI:** [http://dx.doi.org/10.7554/eLife.02286.010](10.7554/eLife.02286.010)Fold change +RB/−RB (SD)[\*](#tblfn9){ref-type="table-fn"}Gene name or IDWT*sak1GPX5*1.13 (0.33)0.87 (0.31)*SAK1*1.38 (0.08)1.29 (0.19)*CFA1*0.90 (0.04)1.44 (0.22)*SOUL2*1.17 (0.25)1.11 (0.19)*MRP3*[†](#tblfn10){ref-type="table-fn"},[‡](#tblfn11){ref-type="table-fn"}1.13 (0.12)1.07 (0.25)Cre12.g503950[†](#tblfn10){ref-type="table-fn"},[‡](#tblfn11){ref-type="table-fn"}0.93 (0.06)1.20 (0.12)Cre14.g613950[†](#tblfn10){ref-type="table-fn"},[§](#tblfn12){ref-type="table-fn"}0.65 (0.06)0.79 (0.15)Cre04.g220850[†](#tblfn10){ref-type="table-fn"},[‡](#tblfn11){ref-type="table-fn"}1.00 (0.09)1.29 (0.04)Cre09.g395750[†](#tblfn10){ref-type="table-fn"},[‡](#tblfn11){ref-type="table-fn"}1.05 (0.10)1.29 (0.12)[^13][^14][^15][^16]

Although only 33% of the up-regulated genes have a functional annotation ([Figure 3B](#fig3){ref-type="fig"}), it is interesting that the ^1^O~2~ response in *Chlamydomonas* involves genes and biological processes that appear to be distinct from those that respond specifically to ^1^O~2~ in *Arabidopsis* ([@bib51]). A total of 70 ^1^O~2~-response genes have been defined using a microarray with the *flu* mutant in *Arabidopsis* ([@bib51]). These genes include the following classes (number of genes): metabolism (11), transcription (5), protein fate (4), transport (2), cellular communication/signal transduction (17), cell rescue/defense in virulence (4), subcellular localization (2), binding function or cofactor requirement (1), transport facilitation (5) and others (19). From this list of 70 genes we found four similarly annotated genes within our 515 genes induced by ^1^O~2~ in *Chlamydomonas*: a Myb transcription factor, a mitochondrial carrier protein, an amino acid permease, and an ATPase/aminophospholipid translocase. None of these genes in *Chlamydomonas* was the closest ortholog of the corresponding *Arabidopsis* gene*.* Conversely, genes similar to those strongly up-regulated in a SAK1-dependent manner such as CFAs, SOUL proteins, GPX, and sterol biosynthetic enzymes were not found among the *Arabidopsis* ^1^O~2~-specific genes despite having clear counterparts in *Arabidopsis*. Taken together, these results suggest that these two organisms may deploy distinct mechanisms in their responses to ^1^O~2~.

The *sak1* mutant is defective in the global gene expression response during acclimation to ^1^O~2~ {#s2-3}
---------------------------------------------------------------------------------------------------

In the *sak1* mutant*,* 1020 genes were up-regulated, whereas 434 genes were down-regulated during acclimation ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}, C2). 350 of the 515 genes up-regulated in WT overlapped with the set of up-regulated genes in the mutant ([Figure 3A](#fig3){ref-type="fig"}). Comparing the fold changes of genes in WT and *sak1* during acclimation, we defined 104 genes as SAK1-dependent genes that displayed moderate to strong attenuation in their response (fold change ratio \<0.5) ([Table 5](#tbl5){ref-type="table"}). Some of the genes that belong to enriched biological classes found among WT up-regulated genes are indicated in [Table 3](#tbl3){ref-type="table"}. Interestingly, the most strongly induced genes in WT were found among this group; 37 out of 104 SAK1-dependent genes were among the top 10% most strongly induced genes ([Table 5](#tbl5){ref-type="table"}). 33 out of these 37 most strongly induced SAK1-dependent genes displayed strong disruption in their up-regulation; reduced to 0.01--0.25 of magnitude of fold change in *sak1* as compared to WT ([Table 5](#tbl5){ref-type="table"}). These results indicate SAK1 is required for the induction of the most strongly induced genes during acclimation reflecting its critical role in regulating the cellular acclimation response to ^1^O~2~.10.7554/eLife.02286.011Table 5.Genes that require *SAK1* for induction by ^1^O~2~**DOI:** [http://dx.doi.org/10.7554/eLife.02286.011](10.7554/eLife.02286.011)Gene ID (v4)Gene ID (v5)Gene nameAnnotationFC WT[\*](#tblfn13){ref-type="table-fn"} (log~2~)FC *sak1* (log~2~)Attenuation (FC-*sak1*/FC-WT)[†](#tblfn14){ref-type="table-fn"}Basal repression in *sak1* (log~2~)Cre02.g137700.t1.1[‡](#tblfn15){ref-type="table-fn"}Cre09.g4004046.491.800.04−3.35Cre06.g281250.t1.1[‡](#tblfn15){ref-type="table-fn"}Cre06.g281250*CFA1*Cyclopropane fatty acid synthase5.921.160.04−2.10Cre27.g775950.t1.2Cre12.g5579285.830.810.03Cre01.g033300.t1.1Cre01.g0333005.72−0.390.01Cre13.g566850.t1.1[‡](#tblfn15){ref-type="table-fn"}Cre13.g566850*SOUL2*SOUL heme-binding protein5.531.330.05−2.60Cre14.g623650.t1.1Cre14.g623650Alcohol dehydrogenase4.891.670.11Cre13.g600650.t1.1Cre06.g278245Rieske 2Fe-2S domain4.761.640.12Cre06.g263550.t1.1Cre06.g263550*LCI7*R53.5-related protein4.461.770.15Cre07.g342100.t1.1Cre07.g3421004.431.400.12Cre06.g299700.t1.1[‡](#tblfn15){ref-type="table-fn"}Cre06.g299700*SOUL1*SOUL heme-binding protein4.320.430.07−1.13Cre09.g398700.t1.1[‡](#tblfn15){ref-type="table-fn"}Cre09.g398700*CFA2*Cyclopropane fatty acid synthase4.050.180.07−1.00Cre12.g492650.t1.1[‡](#tblfn15){ref-type="table-fn"}Cre12.g492650*FAS2*Fasciclin-like protein4.010.070.07−1.24Cre08.g381510.t1.1NF3.940.730.11Cre10.g458450.t1.2Cre10.g458450*GPX5*Glutathione peroxidase3.912.060.28Cre11.g474600.t1.1Cre02.g095151ABC transporter (ABC-2 type)3.900.440.09Cre13.g600700.t1.1Cre06.g2782463.781.480.20Cre14.g613950.t1.1Cre14.g6139503.651.380.21Cre06.g269300.t1.1Cre06.g269300DUF13653.500.400.12Cre08.g380300.t1.2Cre08.g380300*MSRA3*Peptide methionine sulfoxide reductase3.450.660.14Cre28.g776450.t1.1Cre08.g358573*TRP7*Transient receptor potential ion channel3.31−0.790.06Cre01.g031650.t1.2Cre01.g031650*CGLD12*Potential galactosyl transferase activity3.300.670.16Cre14.g629061.t1.1NFDUF21773.250.080.11Cre12.g503950.t1.1Cre12.g503950CRAL/TRIO domain3.240.310.13Cre13.g564900.t1.1Cre13.g564900ABC transporter transmembrane region3.220.340.14Cre02.g139500.t1.1Cre09.g401701DUF12953.04−0.160.11Cre14.g618400.t1.1Cre14.g6184002.971.150.28Cre17.g715150.t1.1Cre17.g7151502.890.130.15Cre17.g741300.t1.2[‡](#tblfn15){ref-type="table-fn"}Cre17.g741300*SAK1*2.880.660.21−2.77Cre01.g007300.t1.1Cre01.g0073002.85−1.150.06Cre16.g648700.t1.2[‡](#tblfn15){ref-type="table-fn"}Cre16.g648700ABC transporter (ABC-2 type)2.790.260.17−1.26Cre13.g566900.t1.2Cre13.g5669002.76−0.380.11Cre02.g137750.t1.2Cre09.g400441JmjC domain2.72−0.310.12Cre06.g263500.t1.1Cre06.g263500Archease protein family (DUF101)2.671.020.32Cre01.g016150.t1.1[‡](#tblfn15){ref-type="table-fn"}Cre01.g016150ADP-ribosylglycohydrolase2.650.170.18−1.26Cre08.g380000.t1.1Cre08.g380000Formylglycine-generating sulfatase enzyme2.591.530.48Cre14.g615600.t1.1Cre14.g615600Putative serine esterase (DUF676)2.53−0.540.12Cre11.g472900.t1.2Cre02.g095113CAP-Gly domain2.45−0.050.18Cre06.g269250.t1.1Cre06.g2692502.440.550.27Cre02.g120600.t1.1Cre09.g4030712.440.940.35Cre06.g261200.t1.1Cre06.g261200*ERG25*Sterol desaturase2.420.640.29Cre16.g683400.t1.1Cre16.g683400CRAL/TRIO domain2.400.080.20Cre22.g765150.t1.1Cre11.g467725hypothetical protein2.300.460.28Cre13.g571800.t1.2Cre13.g571800DUF13362.270.720.34Cre13.g579450.t1.2Cre13.g579450*CST1*Membrane transporter2.271.230.49Cre08.g380350.t1.1Cre08.g3803502.21−0.010.21Cre16.g649250.t1.2Cre16.g6492502.080.580.35Cre11.g476250.t1.1Cre11.g4762502.080.490.33Cre02.g108000.t1.2Cre02.g1080002.081.030.49Cre13.g583300.t1.1Cre13.g5833001.98−0.480.18Cre04.g215300.t1.2NF1.970.570.38Cre02.g139450.t1.1Cre09.g401663DUF9471.95−0.620.17Cre03.g194750.t1.2Cre03.g1947501.950.730.43Cre06.g258600.t1.1Cre06.g258600Dienelactone hydrolase family1.91−0.950.14Cre10.g418700.t1.1Cre10.g418700Probable N6-adenine methyltransferase1.87−0.030.27Cre10.g444550.t1.1Cre10.g444550*SPP1A*Signal peptide peptidase1.810.510.41Cre01.g060050.t1.2Cre03.g1458071.78−0.110.27Cre09.g410050.t1.1Cre09.g410050Calcium transporting ATPase1.760.510.42Cre03.g163400.t1.2Cre03.g1634001.76−0.170.26Cre01.g008450.t1.1Cre01.g008450Nuf2 family1.73−0.540.21Cre12.g536650.t1.1Cre12.g5366501.720.350.39Cre02.g114900.t1.2Cre02.g114900*ANK23*predicted protein1.710.080.32Cre16.g661850.t1.2Cre16.g661850Calcium/calmoduline dependent protein kinase association1.690.030.32Cre14.g615500.t1.2Cre14.g615500Glycoprotease family1.68−0.760.18Cre11.g483100.t1.2Cre11.g483100Protein kinase1.66−0.490.22Cre28.g776650.t1.1Cre08.g3585691.640.330.40Cre07.g340250.t1.2Cre07.g340250Protein kinase1.63−0.410.24Cre06.g296250.t1.2Cre06.g296250*SYK1*tRNA synthetase, class II1.600.540.48Cre06.g310500.t1.1Cre06.g3105001.570.180.38Cre07.g342800.t1.2Cre07.g342800*CGL16*Predicted protein1.490.320.44Cre03.g181450.t1.2Cre03.g181450DUF16191.470.350.46Cre66.g793601.t1.1Cre35.g7594971.470.030.37Cre14.g614050.t1.2Cre14.g614050*MAP65*Microtubule associated protein1.430.060.39Cre04.g217500.t1.1Cre04.g217500Inosine-uridine preferring nucleoside hydrolase1.420.190.43Cre06.g292950.t1.1Cre06.g292950DNA polymerase delta, subunit 41.38−0.120.35Cre16.g661750.t1.1Cre16.g661750Calcium/calmoduline dependent protein kinase association1.38−0.120.35Cre01.g007000.t1.1Cre01.g007000ABC transporter (ABC-2 type)1.350.210.45Cre04.g224400.t1.2Cre04.g224400ABC transporter (ABC-2 type)1.34−0.130.36Cre01.g068400.t1.2Cre16.g6807901.330.160.45Cre05.g237400.t1.1Cre05.g237400*DAE1*Diaminopimelate epimerase1.320.220.47Cre14.g609600.t1.2Cre14.g6096001.32−0.580.27Cre05.g234850.t1.2Cre05.g234850Ubiquitin carboxyl-terminal hydrolase1.290.160.46Cre03.g179200.t1.1Cre03.g1792001.28−0.480.30Cre10.g417730.t1.1Cre10.g4177301.270.170.47Cre03.g159700.t1.2Cre03.g1597001.26−0.140.38Cre12.g540150.t1.2Cre12.g5401501.19−0.240.37Cre01.g006550.t1.2[‡](#tblfn15){ref-type="table-fn"}Cre01.g006550No annotation1.17−0.490.32−1.60Cre03.g159950.t1.2Cre03.g1599501.17−0.170.40Cre27.g775900.t1.2Cre12.g5575031.14−0.700.28Cre02.g121600.t1.1Cre09.g387208Protein kinase1.140.000.46Cre14.g609550.t1.1NF1.13−0.840.26Cre07.g315050.t1.2Cre07.g3150501.12−0.030.45Cre04.g218800.t1.2Cre04.g218800*THB3*Truncated hemoglobin1.11−0.500.33Cre02.g133300.t1.1Cre09.g3966241.11−0.430.34Cre01.g060650.t1.2Cre03.g1460671.10−0.420.35Cre01.g057050.t1.1Cre03.g1443241.100.040.48Cre06.g304950.t1.1Cre06.g3049501.07−0.650.30Cre08.g358200.t1.2Cre08.g358200*A4*Protein kinase1.07−0.820.27Cre16.g689550.t1.2Cre16.g689550*PTK8*Putative tyrosine kinase1.06−0.170.43Cre17.g720950.t1.1Cre17.g7209503-oxo-5-alpha-steroid 4-dehydrogenase1.05−0.260.40Cre02.g090950.t1.2Cre02.g0909501.05−0.270.40Cre16.g683350.t1.1Cre16.g6833501.03−0.670.31Cre02.g109450.t1.1Cre02.g1094501.01−0.030.48Cre16.g652750.t1.1Cre16.g6527501.01−0.290.41Cre03.g190000.t1.1Cre03.g1900001.00−0.990.25[^17][^18][^19][^20]

Classes of up-regulated genes in *sak1* were distinct from those of WT and included secondary metabolism of isoprenoids ([Figure 3C](#fig3){ref-type="fig"}; [Table 6](#tbl6){ref-type="table"}), precursors to photoprotective pigments such as carotenoids and tocopherols ([@bib39]). Phenylpropanoids, a group of metabolites associated with defense against stresses such as ultraviolet light and herbivores ([@bib43]), also represented a larger part of the response in *sak1* as compared to WT ([Figure 3C](#fig3){ref-type="fig"}). Another mutant-specific class of genes was cell vesicular transport, suggesting alteration in cell organization in response to the loss of *SAK1* ([Figure 3C](#fig3){ref-type="fig"}; [Table 6](#tbl6){ref-type="table"}). There were 434 genes that were down-regulated by ^1^O~2~ in the *sak1* mutant ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}, C2), none of which overlapped with the set of down-regulated genes in WT, in contrast to the overlap of up-regulated genes in the two genotypes ([Figure 3A](#fig3){ref-type="fig"}). Enriched classes of genes included those involved in DNA, nucleotide metabolism, hormone metabolism (not of brassinosteroid) and tetrapyrrole metabolism ([Figure 3C](#fig3){ref-type="fig"}, [Table 6](#tbl6){ref-type="table"}).10.7554/eLife.02286.012Table 6.Enriched functional classes among differentially expressed genes in *sak1* during ^1^O~2~ acclimation**DOI:** [http://dx.doi.org/10.7554/eLife.02286.012](10.7554/eLife.02286.012)Primary Mapman classSecondary Mapman classGene ID (v4)Gene nameAnnotationUp-regulated genes Secondary metabolismisoprenoidsCre13.g565650.t1.1Geranylgeranyl pyrophosphate synthase/Polyprenyl synthetaseCre06.g267600.t1.1Lycopene epsilon cyclaseCre09.g407200.t1.1Phytoene desaturaseCre06.g267600.t1.1Lycopene epsilon cyclaseCre01.g011100.t1.1Prenyltransferase and squalene oxidase repeat, Oxidosqualene-lanosterol cyclase and related proteinsN miscCre08.g381707.t1.1NF[\*](#tblfn16){ref-type="table-fn"}phenylpropanoidsCre03.g207800.t1.1Alcohol dehydrogenase, class VCre14.g623650.t1.1Alcohol dehydrogenase, class V (Zinc-binding)Cre01.g039350.t1.1Cytochrome P450 reductase, possibly CYP505B familysulfur-containingCre06.g299400.t1.1NF[\*](#tblfn16){ref-type="table-fn"}waxCre17.g722150.t1.1*PKS3*Type III polyketide synthaseCre07.g318500.t1.2FAE1/Type III polyketide synthase-like protein, Chalcone and stilbene synthases Lipid metabolism'exotics' (steroids, squalene etc)Cre01.g061750.t1.1serine palmitoyltransferaseCre02.g137850.t1.1NF[\*](#tblfn16){ref-type="table-fn"}Cre83.g796250.t1.1NF[\*](#tblfn16){ref-type="table-fn"}Cre01.g011100.t1.1Prenyltransferase and squalene oxidase repeat, Oxidosqualene-lanosterol cyclase and related proteinsFA synthesis and FA elongationCre06.g256750.t1.1Acyl carrier protein thioesteraseCre03.g182050.t1.1Long-chain acyl-CoA synthetases (AMP-forming)Cre02.g074650.t1.1Kelch repeat-containing proteins, Acyl-CoA binding proteiglycerol metabolismCre01.g053000.t1.1*GPD2*Glycerol-3-phosphate dehydrogenase/dihydroxyacetone-3-phosphate reductaseglycolipid synthesisCre13.g583600.t1.1*DGD1*Digalactosyldiacylglycerol synthaselipid degradationCre01.g057450.t1.2NF[\*](#tblfn16){ref-type="table-fn"}Cre02.g126050.t1.1NF[\*](#tblfn16){ref-type="table-fn"}phospholipid synthesisCre06.g281250.t1.1*CFA1*Cyclopropane fatty acid synthaseCre01.g038250.t1.1*SDC1*Serine decarboxylaseCre11.g472700.t1.1NF[\*](#tblfn16){ref-type="table-fn"}Cre13.g604700.t1.2CDP-alcohol phosphatidyltransferase/Phosphatidylglycerol-phosphate synthase Cellvesicle transportCre18.g744100.t1.1NF[\*](#tblfn16){ref-type="table-fn"}Cre17.g721900.t1.1*COG5*Component of oligomeric golgi complexCre01.g003050.t1.1*SEC8*Component of the Exocyst ComplexCre04.g224800.t1.1Endosomal R-SNARE protein, Vamp7/Nyv1-familyCre17.g728150.t1.1Endosomal R-SNARE protein, Yky6-familyCre12.g507450.t1.1Trans-Golgi network Qa-SNARE protein, Syntaxin16/Syx16/Tlg2/Syp4-familyCre03.g210600.t1.1NF[\*](#tblfn16){ref-type="table-fn"}Cre04.g225900.t1.1Endosomal R-SNARE protein, Vamp7/Nyv1-familyCre02.g101400.t1.1*CHC1*Clathrin Heavy ChainCre17.g709350.t1.1Late endosomal Qc-SNARE protein, Syx8/Syntaxin8-familyCre07.g342050.t1.1Endosomal Qb-SNARE, Npsn-familyCre16.g692050.t1.1ER-Golgi Qa-SNARE protein, Syntaxin5/Syx5/Sed5/Syp3-familyCre16.g676650.t1.1*AP1G1*Gamma1-AdaptinCre02.g099000.t1.1Late endosomal Qc-SNARE protein, Syx6/Tlg1/Syp5/6-familyCre12.g554200.t1.2ER-Golgi Qb-SNARE, Memb/GS35/Bos1-familyCre06.g310000.t1.1*AP4E1*Epsilon4-AdaptinCre10.g421250.t1.1*EXO70*Hypothetical Conserved Protein. Similar to Exo70, a subunit of the exocyst complexCre07.g330950.t1.1*AP4S4*Sigma4-AdaptinCre12.g488850.t1.2Adaptin, alpha/gamma/epsilondivisionCre06.g269950.t1.1*CDC48*Protein involved in ubiquitin-dependent degradation of ER-bound substratesCre08.g359200.t1.2Regulator of chromosome condensation (RCC1)organisationCre13.g588600.t1.2Kinesin (SMY1 subfamily)Cre12.g513450.t1.1*TUH1*Eta-TubulinCre01.g010950.t1.226S proteasome regulatory complex, subunit PSMD10 (Ankyrin repeat)Cre16.g679650.t1.2Fimbrin/PlastinCre06.g261950.t1.1Myotrophin and similar proteins (Ankyrin repeat)Cre06.g291700.t1.1*RSP3*Radial spoke protein 3Cre10.g446700.t1.1*ANK28*Ankyrin repeat and DHHC-type Zn-finger domain containing proteins Hormone metabolism[†](#tblfn17){ref-type="table-fn"}abscisic acidCre16.g657800.t1.2*CCD3*Carotenoid cleavage dioxygenaseauxinCre14.g609900.t1.1Predicted membrane protein, contains DoH and Cytochrome b-561/ferric reductase transmembrane domainsbrassinosteroidCre16.g663950.t1.1Sterol C5 desaturaseCre02.g092350.t1.1Cytochrome P450, CYP51 superfamily; sterol 14 desaturaseCre12.g557900.t1.1*CDI1*C-8,7 sterol isomeraseCre02.g076800.t1.1Delta14-sterol reductase, mitochondrialCre12.g500500.t1.224-methylenesterol C-methyltransferaseethyleneCre02.g108450.t1.1*FAP280*Flagellar Associated Protein, transcriptional coactivator-like, putative transcription factorjasmonateCre19.g756100.t1.1NF[\*](#tblfn16){ref-type="table-fn"} Miscacid and other phosphatasesCre09.g396900.t1.1NADH pyrophosphatase I of the Nudix family of hydrolasesCre06.g259650.t1.1Calcineurin-like phosphoesterase, Acid-phosphatase-relatedCre06.g249800.t1.1Sphingomyelin synthetase -relatedcytochrome P450Cre05.g234100.t1.1Cytochrome P450, CYP197 superfamilydynaminCre02.g079550.t1.1*DRP2*Dynamin-related GTPase, involved in circadian rhythmsCre05.g245950.t1.1*DRP1*Dynamin-related GTPaseglutathione S transferasesCre03.g154950.t1.1Glutathione S-transferasemisc2Cre12.g538450.t1.1*EPT1*CDP-Etn:DAG Ethanolamine phosphotransferaseshort chain dehydrogenase/reductase (SDR)Cre12.g556750.t1.2Short-chain dehydrogenase/reductaseCre08.g384864.t1.1SH3 domain, protein bindingCre27.g775000.t1.1NF[\*](#tblfn16){ref-type="table-fn"}Cre17.g731350.t1.2Short chain dehydrogenaseUDP glucosyl and glucoronyl transferasesCre02.g111150.t1.2*ELG26*Exostosin-like glycosyltransferaseCre02.g144050.t1.1Acetylglucosaminyltransferase EXT1/exostosin 1Cre03.g204050.t1.2*ELG6*Exostosin-like glycosyltransferasesCre11.g474450.t1.1NF[\*](#tblfn16){ref-type="table-fn"}Cre03.g173300.t1.1Lactosylceramide 4-alpha-galactosyltransferase (alpha- 1,4-galactosyltransferase)Cre02.g116600.t1.1*ELG23*Exostosin-like glycosyltransferaseDown-regulated genes Hormone metabolism[†](#tblfn17){ref-type="table-fn"}cytokininCre18.g744950.t1.2NF[\*](#tblfn16){ref-type="table-fn"}Cre16.g678900.t1.1Response regulator receiver domainCre01.g040450.t1.1*HDT1*Histidine-aspartic acid phosphotransferase 1 (phosphorylation cascade)ethyleneCre09.g403550.t1.1Iron/ascorbate family oxidoreductases Nucleotide metabolismdeoxynucleotide metabolismCre12.g491050.t1.1*RIR2*Ribonucleotide reductase (RNR), small subunitCre12.g492950.t1.1*RIR1*Ribonucleotide reductase (RNR), large subunit, class ICre16.g667850.t1.1dUTP pyrophosphatasesynthesisCre14.g614300.t1.1Inosine-5-monophosphate dehydrogenase/GMP reductaseCre07.g318750.t1.1Phosphoribosylformylglycinamidine cyclo-ligase Tetrapyrrole synthesisporphobilinogen deaminaseCre16.g663900.t1.1Porphobilinogen deaminaseprotochlorophyllide reductaseCre01.g015350.t1.1Light-dependent protochlorophyllide reductaseurogen III methylaseCre02.g133050.t1.2NF[\*](#tblfn16){ref-type="table-fn"} DNArepairCre16.g670550.t1.2XP-G/RAD2 DNA repair endonucleasesynthesis/chromatin structureCre07.g338000.t1.1*MCM2*Minichromosome maintenance proteinCre07.g314900.t1.2ATP-dependent RNA helicase, DEAD/DEAH helicaseCre03.g172950.t1.1*CBF5*Centromere/microtubule binding proteinCre01.g015250.t1.1Eukaryotic DNA polymerase deltaCre27.g774200.t1.2NF[\*](#tblfn16){ref-type="table-fn"}Cre07.g316850.t1.1*MCM4*Minichromosome maintenance proteinunspecifiedCre10.g451250.t1.2Adenylate and guanylate cyclase catalytic domain, 3-5 exonucleaseCre01.g059950.t1.2NF[\*](#tblfn16){ref-type="table-fn"}[^21][^22]

To better understand the physiology of *sak1,* including the primary and secondary effects of lacking SAK1, we also focused on changes in transcript levels at the basal level, that is, without ^1^O~2~ treatment. At basal level 699 genes were induced, and 737 genes were repressed in the mutant compared to WT ([Supplementary file 1](#SD1-data){ref-type="supplementary-material"}, C3), displaying the genome-wide response to the loss of *SAK1* function despite the mutant's wild-type appearance under normal lab growth conditions ([Figure 1D](#fig1){ref-type="fig"}). The enriched classes of genes that are differentially expressed are shown in [Figure 3D](#fig3){ref-type="fig"}. Genes induced in the mutant at basal level were enriched for those annotated to be involved in nucleotide metabolism, DNA, and RNA ([Figure 3D](#fig3){ref-type="fig"}; [Table 7](#tbl7){ref-type="table"}). Interestingly genes involved in tetrapyrrole and photosynthesis were enriched both in elevated and repressed genes at the basal level in *sak1*. There was no overall trend of these two pathways being up- or down-regulated, since these genes were at different steps of the pathway or encoded a select isoform of an enzyme or a subunit of a complex ([Figure 3D](#fig3){ref-type="fig"}; [Table 7](#tbl7){ref-type="table"}).10.7554/eLife.02286.013Table 7.Enriched functional classes among differentially expressed genes in *sak1* at basal level**DOI:** [http://dx.doi.org/10.7554/eLife.02286.013](10.7554/eLife.02286.013)Primary Mapman classSecondary Mapman classGene ID (v4)Gene nameAnnotationElevated in *sak1* nucleotide metabolismdeoxynucleotide metabolismCre12.g491050.t1.1*RIR2*Ribonucleotide reductase (RNR), small subunitCre12.g492950.t1.1*RIR1*Ribonucleotide reductase (RNR), large subunit, class ICre16.g667850.t1.1dUTP pyrophosphatasephosphotransfer and pyrophosphatasesCre02.g122450.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre02.g093950.t1.1*PYR5*Uridine 5\'- monophosphate synthase/orotate phosphoribosyltransferaseCre12.g519950.t1.1Flagellar Associated Protein similar to adenylate/guanylate kinasesCre26.g772450.t1.1NF[\*](#tblfn18){ref-type="table-fn"}synthesisCre65.g793400.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre02.g079700.t1.1*PYR2*Aspartate carbamoyltransferaseCre01.g048950.t1.1dUTP pyrophosphataseCre07.g318750.t1.1Phosphoribosylformylglycinamidine cyclo-ligase. DNArepairCre07.g314650.t1.1Chloroplast RecA recombination proteinsynthesis/chromatin structureCre04.g214350.t1.2Eukaryotic DNA polymerase alpha, catalytic subunitCre07.g314900.t1.2ATP-dependent RNA helicase (DEAD/DEAH)Cre04.g223850.t1.1Cytoplasmic DExD/H-box RNA helicaseCre01.g015250.t1.1Eukaryotic DNA polymerase delta, catalytic subunit.Cre07.g342506.t1.1Ubiquitin-protein ligaseCre07.g338000.t1.1*MCM2*Minichromosome maintenance proteinCre03.g178650.t1.1*MCM6*MCM6 DNA replication proteinCre07.g312350.t1.2DNA polymerase alpha, primase subunitCre01.g009250.t1.2*TOP2*DNA topoisomerase IICre26.g772150.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre07.g316850.t1.1*MCM4*Minichromosome maintenance protein 4Cre06.g263800.t1.2tRNA-splicing endonuclease positive effector (SEN1)Cre06.g295700.t1.2*MCM3*Minichromosome maintenance proteinCre06.g251800.t1.1*RFC4*DNA replication factor C complex subunit 4unspecifiedCre07.g322300.t1.2DNA repair helicase of the DEAD superfamilyCre17.g718100.t1.1Phosphatidylinositol transfer protein SEC14 and related proteins (CRAL/TRIO) Tetrapyrrole synthesisGlu-tRNA reductaseCre07.g342150.t1.1*HEM1*Glutamyl-tRNA reductaseGlu-tRNA synthetaseCre44.g788000.t1.1Glutamyl-tRNA reductaseCre06.g306300.t1.1*CHLI1*Magnesium chelatase subunit Imagnesium chelataseCre07.g325500.t1.1Magnesium chelatase subunit Hprotochlorophyllide reductaseCre01.g015350.t1.1*POR1*Light-dependent protochlorophyllide reductase PhotosynthesisCalvin-Benson cycleCre05.g234550.t1.1Fructose-biphosphate aldolaselight reactionCre07.g330250.t1.1*PSAH*Subunit H of photosystem ICre07.g334550.t1.1Photosystem I subunit PsaOCre06.g261000.t1.1*PSBR*10 kDa photosystem II polypeptidephotorespirationCre12.g542300.t1.1*GYK1*Glycerate kinaseCre06.g253350.t1.1*GCSH*Glycine cleavage system, H-proteinCre06.g293950.t1.1*SHMT2*Serine hydroxymethyltransferase 2 TransportABC transporters and multidrug resistance systemsCre04.g222700.t1.1ATPase component of ABC transporters with duplicated ATPase domains/Translation elongation factor EF-3bCre17.g728400.t1.2ABCtransporter (ABC-2 type)Cre05.g241350.t1.2ABCtransporter (ABC-2 type)Cre03.g169300.t1.1ABCtransporter (ABC-2 type)Cre11.g474600.t1.1NF[\*](#tblfn18){ref-type="table-fn"}amino acidsCre04.g226150.t1.2*AOC1*Amino acid carrier 1; belongs to APC (Amino acid Polyamine organo Cation) familycalciumCre09.g388850.t1.1*ACA1*P-type ATPase/cation transporter, plasma membranemetabolite transporters at the envelope membraneCre06.g263850.t1.2*TPT2*Triose phosphate/phosphate translocatormetabolite transporters at the mitochondrial membraneCre10.g449100.t1.1Mitochondrial oxodicarboxylate carrier proteinCre01.g069350.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre15.g641200.t1.1Mitochondrial fatty acid anion carrier protein/Uncoupling proteinCre09.g396350.t1.1Mitochondrial carrier protein PET8miscCre06.g311000.t1.2*FBT2*Folate transporteCre17.g718100.t1.1Phosphatidylinositol transfer protein SEC14 and related proteins (CRAL/TRIO)phosphateCre16.g686750.t1.1*PTA3*Proton/phosphate symporterCre16.g675300.t1.2Sodium-dependent phosphate transporter, major facilitator superfamilypotassiumCre12.g553450.t1.2NF[\*](#tblfn18){ref-type="table-fn"}sulphateCre17.g723350.t1.1*SUL2*Sulfate anion transporterunspecified cationsCre13.g573900.t1.1Na+:iodide/myo-inositol/multivitamin symporterssugarsCre16.g675300.t1.2Sodium-dependent phosphate transporter, major facilitator superfamily RNAprocessingCre10.g427700.t1.1ATP-dependent RNA helicase, DEAD/DEAH box helicaseCre12.g538750.t1.1*LSM1*U6 snRNA-associated Sm-like protein LSm1, RNA cap binding; (SMP6d)Cre10.g433750.t1.2*PAP1*Nuclear poly(A) polymeraseCre03.g182950.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre08.g375128.t1.1NF[\*](#tblfn18){ref-type="table-fn"}regulation of transcriptionCre17.g728200.t1.2YL-1 protein (transcription factor-like 1)Cre06.g275500.t1.1AP2 Transcription factorCre28.g777500.t1.2NF[\*](#tblfn18){ref-type="table-fn"}Cre13.g572450.t1.1Response regulator receiver domain (sensor histidine kinase-related, regulation of transcription)Cre14.g620500.t1.1AP2 Transcription factorCre16.g673150.t1.1Histone deacetylase complex, catalytic component RPD3Cre02.g078700.t1.2DNA damage-responsive repressor GIS1/RPH1, jumonji superfamilyCre03.g198800.t1.1Myb-like DNA-binding domainCre04.g218050.t1.2RWP-RK domainCre07.g324400.t1.1*VPS24*Subunit of the ESCRT-III complex, vaculoar sortin proteinCre11.g481050.t1.1SWI/SNF-related chromatin binding proteinCre02.g101950.t1.1*TMU2*tRNA (uracil-5)-methyltransferaseCre10.g459600.t1.2CAATT-binding transcription factor/60S ribosomal subunit biogenesis proteinCre01.g018650.t1.2NF[\*](#tblfn18){ref-type="table-fn"}Cre01.g012200.t1.2NF[\*](#tblfn18){ref-type="table-fn"}Cre02.g129750.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre10.g461750.t1.2DNA (cytosine-5-)-methyltransferaseCre01.g004600.t1.2*RWP12*Putative RWP-RK domain transcription factorCre09.g400100.t1.1Predicted Zn-finger protein, zinc and DNA binding domainsCre07.g335150.t1.2SBP domainRNA bindingCre16.g662700.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre07.g330300.t1.1RNA-binding protein musashi/mRNA cleavage and polyadenylation factor I complex, subunit HRP1Cre06.g275100.t1.1RNA-binding protein musashi/mRNA cleavage and polyadenylation factor I complex, subunit HRP1transcriptionCre07.g322200.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Repressed in *sak1* TransportABC transporters and multidrug resistance systemsCre02.g097800.t1.2ABC transporter (MDR)Cre17.g725200.t1.1ABC transporter, peptide exporterCre13.g580300.t1.1ABC transporter family proteinCre10.g439000.t1.2Long-chain acyl-CoA transporter, ABC superfamily (involved in peroxisome organization and biogenesis)amino acidsCre06.g292350.t1.1*AOC4*Amino acid carriercalciumCre06.g263950.t1.2Sodium/potassium-transporting ATPase subunit alphaCre16.g681750.t1.2Calcium transporting ATPasemetabolite transporters at the mitochondrial membraneCre03.g172300.t1.1Mitochondrial phosphate carrier proteinCre09.g394800.t1.2Mitochondrial substrate carrier proteinmetalCre03.g189550.t1.2*ZIP3*Zinc transporter, ZIP familyCre11.g479600.t1.2Sodium/calcium exchanger NCX1 and related proteinsCre06.g281900.t1.1*ZIP7*Zinc transporter and related ZIP domain-containing proteinsmiscCre02.g089900.t1.1Secretory carrier membrane proteinCre10.g448050.t1.1Retinaldehyde binding protein-related (CRAL/TRIO domain)Cre03.g177750.t1.2Multidrug resistance pumpNDP-sugars at the ERCre02.g112900.t1.1GDP-fucose transporter (Triose-phosphate transporter family)P- and V-ATPasesCre01.g027800.t1.1*ATPvH*Vacuolar ATP synthase subunit HCre10.g446550.t1.1*ATPvF*Vacuolar ATP synthase subunit FCre03.g176250.t1.1*ATPvD1*Vacuolar ATP synthase subunit DCre06.g250250.t1.1*ATPvC*Vacuolar ATP synthase subunit CCre10.g459200.t1.1*ACA4*P-type ATPase/cation transporter, plasma membrane (Low CO2 inducible gene)phosphateCre12.g515750.t1.2Sodium-dependent phosphate transporter-relatedCre08.g379550.t1.2Sodium-dependent phosphate transporter, major facilitator superfamilyCre12.g489400.t1.1*PTB7*Putative phosphate transporter, sodium/phosphate transporterCre02.g144650.t1.1*PTB12*Sodium/phosphate symporterunspecified anionsCre09.g404100.t1.1Cl- channel CLC-7 and related proteins (CLC superfamily)Cre17.g729450.t1.1Cl- channel CLC-7 and related proteins (CLC superfamily)Cre01.g037150.t1.2Voltage-gated chloride channel activitysugarsCre03.g206800.t1.2*HXT1*Hexose transporterP- and V-ATPasesCre03.g176250.t1.1*ATPvD1*Vacuolar ATP synthase subunit DCre10.g446550.t1.1*ATPvF*Vacuolar ATP synthase subunit FCre01.g027800.t1.1*ATPvH*Vacuolar ATP synthase subunit H Mitochondrial electron transport / ATP synthesiscytochrome c reductaseCre01.g051900.t1.1*RIP1*Rieske iron-sulfur protein of mitochondrial ubiquinol-cytochrome c reductase (complex III)Cre06.g262700.t1.2Ubiquinol cytochrome c reductase, subunit 7F~1~-ATPaseCre02.g116750.t1.2F0F1-type ATP synthase, alpha subunitCre01.g018800.t1.1*ATP6*Mitochondrial F1F0 ATP synthase subunit 6Cre10.g420700.t1.1Mitochondrial F1F0-ATP synthase, subunit epsilon/ATP15Cre16.g680000.t1.1*ATP5*Mitochondrial ATP synthase subunit 5, OSCP subunitNADH-DHCre10.g434450.t1.1*NUOA9*Putative NADH:ubiquinone oxidoreductase (Complex I) 39 kDa subunitCre08.g378900.t1.1*NUO3*NADH:ubiquinone oxidoreductase ND3 subunitCre10.g450400.t1.1*NUO5*NADH:ubiquinone oxidoreductase (Complex I) 24 kD subunit Lipid metabolism\'exotics\' (steroids, squalene etc)Cre14.g615050.t1.13-oxo-5-alpha-steroid 4-dehydrogenase, Steroid reductase required for elongation of the VLCFAs (enoyl reductase)Cre12.g530550.t1.2*KDG2*Diacylglycerol kinase, sphingosine kinaseCre02.g137850.t1.1NF[\*](#tblfn18){ref-type="table-fn"}FA desaturationCre17.g711150.t1.1Omega-6 fatty acid desaturase (delta-12 desaturase)glyceral metabolismCre13.g577450.t1.2Glycerol-3-phosphate dehydrogenaseglycolipid synthesisCre13.g583600.t1.1*DGD1*Digalactosyldiacylglycerol synthaseCre16.g656400.t1.1*SQD1*UDP-sulfoquinovose synthaselipid degradationCre06.g252801.t1.2CGI-141-related/lipase containing protein (TAG lipase)Cre03.g164350.t1.2Lysophospholipase, putative drug exporter of the RND superfamilyphospholipid synthesisCre06.g281250.t1.1*CFA1*Cyclopropane fatty acid synthaseCre09.g398700.t1.1*CFA2*Cyclopropane fatty acid synthaseCre11.g472700.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre06.g262550.t1.1Zinc finger MYND domain containing protein 10 PhotosynthesisCalvin-Benson cycleCre12.g511900.t1.1*RPE1*Ribulose phosphate-3-epimeraseCre02.g120100.t1.1*RBCS1*Ribulose-1,5-bisphosphate carboxylase/oxygenase small subunit 1light reactionCre05.g243800.t1.1*CPLD45*Photosystem II Psb27 proteinCre10.g420350.t1.1*PSAE*Photosystem I reaction center subunit IVCre01.g071450.t1.2NF[\*](#tblfn18){ref-type="table-fn"}Cre06.g291650.t1.1FerredoxinCre05.g242400.t1.1No functional annotationphotorespirationCre09.g411900.t1.2*SHMT3*Serine hydroxymethyltransferase 3Cre06.g295450.t1.1*HPR1*Hydroxypyruvate reductaseMajor CHO metabolismdegradationCre09.g415600.t1.2Starch binding domainCre11.g473500.t1.2NF[\*](#tblfn18){ref-type="table-fn"}Cre09.g415600.t1.2Starch binding domainsynthesisCre06.g289850.t1.2*SBE1*Starch Branching EnzymeCre17.g721500.t1.1Granule-bound starch synthase I miscacid and other phosphatasesCre13.g568600.t1.2Multiple inositol polyphosphate phosphatase-related, Acid phosphatase activityalcohol dehydrogenasesCre13.g569350.t1.1Sterol dehydrogenase-related, Flavonol reductase/cinnamoyl-CoA reductasecytochrome P450Cre07.g356250.t1.2Cytochrome P450 CYP4/CYP19/CYP26 subfamilies, beta-carotene 15,15\'-monooxygenaseCre07.g356250.t1.2Cytochrome P450 CYP4/CYP19/CYP26 subfamilies, beta-carotene 15,15\'-monooxygenasedynaminCre17.g724150.t1.1*DRP3*Dynamin-related GTPaseGCN5-related N-acetyltransferaseCre16.g657150.t1.2N-acetyltransferase activity (GNAT) familygluco-, galacto- and mannosidasesCre03.g171050.t1.2*GHL1*Glycosyl hydrolasemisc2Cre14.g614100.t1.1*GTR26*Dolichyl-diphosphooligosaccharide-protein glycosyltransferaserhodaneseCre07.g352550.t1.1*RDP3*Putative rhodanese domain phosphataseshort chain dehydrogenase/reductase (SDR)Cre07.g352450.t1.1Corticosteroid 11-beta-dehydrogenase and related short chain-type dehydrogenases, 3-hydroxybutyrate dehydrogenaseCre12.g559350.t1.11-Acyl dihydroxyacetone phosphate reductase and related dehydrogenasesCre03.g191850.t1.1Short chain dehydrogenaseUDP glucosyl and glucoronyl transferasesCre11.g474450.t1.1NF[\*](#tblfn18){ref-type="table-fn"}Cre03.g205250.t1.2*ELG4*Exostosin-like glycosyltransferaseCre16.g659500.t1.1Lactosylceramide 4-alpha-galactosyltransferaseCre11.g483400.t1.2*ELG10*Exostosin-like glycosyltransferase Tetrapyrrole synthesisGlu-tRNA synthetaseCre12.g510800.t1.1*CHLI2*Magnesium-chelatase subunit chlImagnesium protoporphyrin IX methyltransferaseCre12.g498550.t1.2Magnesium protoporphyrin IX S-adenosyl methionine O-methyl transferase (Magnesium-protoporphyrin IX methyltransferase) (PPMT)unspecifiedCre12.g516350.t1.1*COX10*Cytochrome c oxidase assembly protein Cox10urogen III methylaseCre02.g133050.t1.2NF[\*](#tblfn18){ref-type="table-fn"}[^23]

We observed that some of the genes more strongly dependent on *SAK1* had repressed transcript levels (e.g., *CFA1* and *SOUL2*), indicating that *SAK1* is required for their basal expression, while others had elevated basal levels (*GPX5*), suggesting that expression of these genes is controlled also by other pathways. As is discussed in the following section, *SAK1* expression monitored by qRT-PCR followed the latter trend as the 5′UTR of the gene was elevated in the mutant ([Figure 4E](#fig4){ref-type="fig"}), which may be a result of response to other factors such as a possible oxidization product of ^1^O~2~. The SAK1-dependent genes induced by ^1^O~2~ and repressed at basal level in the mutant (i.e., those that require *SAK1* for basal expression) are indicated in [Table 5](#tbl5){ref-type="table"}.10.7554/eLife.02286.014Figure 4.Genetic and molecular analysis of *sak1.*(**A**) The insertion of a zeocin resistance gene and the RB sensitivity phenotype are linked. Twelve complete tetrads from a backcross of *sak1* to wild type are shown. Numbers indicate independent tetrads, and letters (a-d) indicate the individual progeny from tetrads. (**B**) Gene structure of *SAK1* and the insertion site. Gray boxes indicate positions of primers used for qPCR. (**C**) Transformation of *sak1* with a genomic fragment containing *SAK1* rescues the acclimation phenotype. *sak1*(g*SAK1*)-1 and *sak1*(g*SAK1*)-2 are two independent transformants. (**D**) *sak1*(g*SAK1*)-1 and *sak1*(g*SAK1*)-2 show recovery of ^1^O~2~ target gene expression. Y-axis indicates fold change during acclimation to ^1^O~2~. (**E**) qRT-PCR of *SAK1* in WT and *sak1* mutant using primers for 5′- and 3′-UTR shown in panel **B**. (**F**) SAK1 protein is induced in WT and detected as higher molecular weight bands during acclimation to ^1^O~2~ generated by RB. (**G**) *SAK1* transcript probed for 5′-UTR in cells transferred from low light to high light for 1 hr. Error bars indicate standard deviation of biological triplicates.**DOI:** [http://dx.doi.org/10.7554/eLife.02286.014](10.7554/eLife.02286.014)

The *sak1* mutant identifies a single nuclear gene that is itself induced during acclimation to ^1^O~2~ {#s2-4}
-------------------------------------------------------------------------------------------------------

The *sak1* mutant was generated by insertional mutagenesis using a plasmid that confers resistance to zeocin ([@bib15]). Progeny obtained from a backcross of *sak1* with WT showed that the mutation causing the RB sensitivity phenotype was linked to zeocin resistance ([Figure 4A](#fig4){ref-type="fig"}). The site of insertion was identified by thermal asymmetric interlaced (TAIL)-PCR ([@bib40]) as the second exon of the annotated gene Cre17.g741300 on chromosome 17 ([Figure 4B](#fig4){ref-type="fig"}). To test whether this gene is responsible for the mutant phenotype, a genomic fragment containing the gene with an additional ∼500 bp region upstream of the predicted transcription start site was cloned and introduced into the mutant by co-transformation. Among the approximately 300 transformants screened, two clones appeared to have recovered the RB acclimation phenotype ([Figure 4C](#fig4){ref-type="fig"}). Furthermore, induction of genes we found attenuated in *sak1* ([Figure 2](#fig2){ref-type="fig"}) was restored in these transformants ([Figure 4D](#fig4){ref-type="fig"}), confirming that Cre17.g741300 is the *SAK1* gene required for acclimation and the gene expression response to ^1^O~2~.

In WT, the *SAK1* gene itself was induced by 6- to 10-fold during acclimation when probed for the 5′-and 3′-UTR of the transcript by qRT-PCR ([Figure 4E](#fig4){ref-type="fig"}). The mutant displayed elevated basal level and induction of the 5′-UTR during acclimation, whereas the 3′-UTR of the transcript was undetectable, indicating that the full-length transcript was absent in *sak1* ([Figure 4E](#fig4){ref-type="fig"}). An antibody raised against an epitope of the SAK1 protein detected a single band in basal conditions, whereas the SAK1 protein appeared as multiple bands with higher molecular weight in acclimated WT cells, all of which were absent in the mutant ([Figure 4F](#fig4){ref-type="fig"}). *SAK1* transcript was induced when probed for the 5′-UTR during high light exposure in both WT and *sak1* ([Figure 4G](#fig4){ref-type="fig"}) similarly to other ^1^O~2~-response genes identified by RNA-seq ([Table 1](#tbl1){ref-type="table"}), indicating that *SAK1* itself is part of the endogenous response to high light.

SAK1 contains an uncharacterized domain conserved in chlorophytes and found in some bZIP transcription factors {#s2-5}
--------------------------------------------------------------------------------------------------------------

The predicted SAK1 protein consists of 1141 amino acid residues and has no domains with functional annotation. Only a ∼150-residue region at the C-terminus, designated the SAK1 domain, has similarity to other proteins. Many predicted proteins within chlorophytes (*Volvox carteri* \[8 proteins\], *Coccomyxa subellipsoidea* \[3 proteins\], *Chlamydomonas* \[14 proteins\], *Chlorella variabilis* \[9 proteins\] and *Micromonas* \[3 proteins\]) ([Table 8](#tbl8){ref-type="table"}) contain this domain as shown in the alignment in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}. Among the 37 members of the chlorophyte SAK1 domain family, 13 have possible bZIP transcription factor domains (six were significant Pfam hits and seven were below the threshold for significance but recognizable by Pfam) ([Figure 5](#fig5){ref-type="fig"}). One protein contained a mitochondrial (transcription) termination factor (mTERF) domain ([Figure 5](#fig5){ref-type="fig"}), defined by its three leucine zipper domains required for DNA binding ([@bib20]). Proteins with more distantly related SAK1 domains were found by PSI-BLAST in plants, many of which were hypothetical or unknown proteins but also included bZIP transcription factors.10.7554/eLife.02286.015Table 8.SAK1 domain containing proteins in chlorophytes**DOI:** [http://dx.doi.org/10.7554/eLife.02286.015](10.7554/eLife.02286.015)Number in alignmentOrganismTranscript/Protein IDaTranscript/Protein IDaTranscript/Protein ID[\*](#tblfn19){ref-type="table-fn"}1*Volvox carteri*Vocar200092352*Volvox carteri*Vocar200024373*Volvox carteri*Vocar200026724*Volvox carteri*Vocar200049235*Volvox carteri*Vocar200123496*Volvox carteri*Vocar200059887*Volvox carteri*Vocar200071588*Volvox carteri*Vocar200078839*Coccomyxa subellipsoidea*5740510*Coccomyxa subellipsoidea*5965511*Coccomyxa subellipsoidea*5769412*Chlamydomonas reinhardtii*Cre16.g652650.t1.313*Chlamydomonas reinhardtii*Cre06.g271000.t1.214*Chlamydomonas reinhardtii*Cre06.g285800.t1.215*Chlamydomonas reinhardtii*Cre06.g275600.t1.216*Chlamydomonas reinhardtii*Cre06.g285750.t1.317*Chlamydomonas reinhardtii*Cre06.g270950.t1.218*Chlamydomonas reinhardtii*g9774.t1SAK1*Chlamydomonas reinhardtii*KF98524220*Chlamydomonas reinhardtii*Cre03.g179150.t1.221*Chlamydomonas reinhardtii*g3701.t122*Chlamydomonas reinhardtii*Cre03.g179250.t1.223*Chlamydomonas reinhardtii*Cre03.g179200.t1.224*Chlamydomonas reinhardtii*Cre01.g004800.t1.225*Chlamydomonas reinhardtii*Cre01.g048550.t1.326*Chlorella variabilis*EFN5126027*Chlorella variabilis*EFN5349628*Chlorella variabilis*EFN5561829*Chlorella variabilis*EFN5765230*Chlorella variabilis*EFN5565831*Chlorella variabilis*EFN5426232*Chlorella variabilis*EFN5451033*Chlorella variabilis*EFN5580634*Chlorella variabilis*EFN5349235*Micromonas sp. RCC299*ACO6134736*Micromonas pusilla CCMP1545*EEH5779137*Micromonas sp. RCC299*ACO65814[^24]10.7554/eLife.02286.016Figure 5.SAK1 contains an uncharacterized domain present in some bZIP transcription factors.Schematic of relative positions of SAK1 and bZIP domains. One protein (Cv28) contains a mitochondrial termination factor (mTERF) domain. The letters and numbers in the abbreviated names represent initials of the species and numbers listed in [Table 8](#tbl8){ref-type="table"}. Proteins with italicized names contain bZIP domains that were recognized by Pfam but scored below significance.**DOI:** [http://dx.doi.org/10.7554/eLife.02286.016](10.7554/eLife.02286.016)10.7554/eLife.02286.017Figure 5---figure supplement 1.Multiple sequence alignment of SAK1 domains.The SAK1 domains of 37 chlorophyte proteins were aligned by MUSCLE (phylogeny.fr). Protein identities are as shown in [Table 8](#tbl8){ref-type="table"}. Star indicates a relatively conserved residue within the SAK1 domain that was predicted to be a possible phosphorylation site ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}).**DOI:** [http://dx.doi.org/10.7554/eLife.02286.017](10.7554/eLife.02286.017)10.7554/eLife.02286.018Figure 5---figure supplement 2.Secondary structure prediction of SAK1 domain.SAK1 domain modeled against its best-hit nickel cobalt resistance protein cnrr by PHYRE. 44% (coverage) of the SAK1 domain was aligned with 73.6% confidence.**DOI:** [http://dx.doi.org/10.7554/eLife.02286.018](10.7554/eLife.02286.018)10.7554/eLife.02286.019Figure 5---figure supplement 3.Prediction of phosphorylation sites in SAK1.Prediction of phosphorylation sites by NetPhos 2.0. Orange bar indicates the position of SAK1 domain, star indicates a relatively conserved residue among the 37 members containing the SAK1 domain.**DOI:** [http://dx.doi.org/10.7554/eLife.02286.019](10.7554/eLife.02286.019)

Amino acid positions 900 to 1089 of SAK1, corresponding to the region aligned with other proteins in [Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}, were searched for secondary structure using PHYRE, and this region was predicted to consist of mostly alpha helices with some disordered intervals. The top hit was a cobalt/nickel-binding resistance protein cnrr, and 44% of the residues were modeled with 73.6% confidence ([Figure 5---figure supplement 2](#fig5s2){ref-type="fig"}).

SAK1 resides mainly in the cytosol and is phosphorylated during induction by ^1^O~2~ {#s2-6}
------------------------------------------------------------------------------------

To obtain insight into the function of SAK1, we isolated subcellular fractions enriched for chloroplast, ER, cytosol, and mitochondria from WT cells. The *Chlamydomonas* cell contains a single large chloroplast that is physically connected to other organelles such as the ER, making it particularly challenging to fractionate. The patterns of markers specific for chloroplast, ER, cytosol, and mitochondria showed that each target fraction was enriched as expected, although with some cross contamination ([Figure 6A,B](#fig6){ref-type="fig"}). The distribution of SAK1 in these fractions resembled most closely that of the cytosolic marker NAB1 ([@bib48]), although the SAK1 signal was not as enriched as NAB1 in the cytosolic fraction, possibly due to partial degradation of SAK1 during the fractionation. The localization was the same in cells with and without RB treatment ([Figure 6A](#fig6){ref-type="fig"}). Because *SAK1* was required for the induction of many genes during acclimation to ^1^O~2~ and the list of proteins with similarity to SAK1 included those predicted to be bZIP transcription factors, we tested whether SAK1 protein was dually targeted to the nucleus and cytosol, which would account for the lack of enrichment of SAK1 in the cytosolic fraction ([Figure 6A](#fig6){ref-type="fig"}). As shown in [Figure 6C](#fig6){ref-type="fig"} although a faint SAK1 signal was detected in nuclear fraction, there was no enrichment as seen for the nuclear marker histone H3 (H3). The distribution of the cytosolic marker NAB1 indicated the contamination of the nuclear fraction by cytosolic proteins ([Figure 6C](#fig6){ref-type="fig"}). Therefore we conclude that the low signal of SAK1 in the nuclear fraction is likely to be due to cytosolic contamination. Attempts to detect the protein by immunofluorescence using anti-SAK1 antibodies as well as anti-FLAG and anti-HA antibodies against tagged proteins in transgenic lines were unsuccessful due to a very low signal-to-noise ratio even in bleached cells.10.7554/eLife.02286.020Figure 6.SAK1 is a phosphorylated protein that is in the cytosol.(**A** and **B**) SAK1 is detected in the cytosol and not in other subcellular fractions. (**C**) SAK1 is not enriched in nuclear extracts. Approximately 30 μg of protein was loaded into each well except for mitochondrial fractions that were loaded approximately 7.5 μg protein due to low protein yield in isolated fractions. Subcellular markers: Chloroplast (CP), PSAD; Endoplasmic reticulum (ER), KDEL; Cytosol, NAB1; Mitochondria (mito), cytochrome *c* (Cyt c); Nuclear, histone 3 (H3). The arrowhead indicates the band corresponding to Cyt *c*. (**D**) Protein extracts from cells treated with increasing concentrations of RB were then treated with phosphatase (+) or only with buffer (−) before detection of SAK1 by immunoblot analysis.**DOI:** [http://dx.doi.org/10.7554/eLife.02286.020](10.7554/eLife.02286.020)

By SDS-PAGE and immunoblot analysis, SAK1 appeared in multiple forms with higher molecular weight during acclimation compared to that observed in control cells ([Figures 4F and 6A,C](#fig4 fig6){ref-type="fig"}). When the extracted protein samples were treated with phosphatase, the diffuse pattern of multiple forms collapsed into a single band detected by immunoblot analysis that had an even higher mobility that that of untreated cells ([Figure 6D](#fig6){ref-type="fig"}). This result indicates that SAK1 is a phosphorylated protein during basal conditions, and it is further phosphorylated upon exposure of cells to ^1^O~2~.

Discussion {#s3}
==========

*SAK1* is necessary for acclimation of *Chlamydomonas* cells to ^1^O~2~ {#s3-1}
-----------------------------------------------------------------------

To understand the retrograde signal transduction pathway involved in the cellular response to ^1^O~2~, we focused on the unique ability of *Chlamydomonas* to acclimate to ^1^O~2~ stress ([@bib35]), and we isolated a regulatory mutant that is unable to acclimate. Several previous genetic screens aimed at dissecting the mechanisms of ^1^O~2~ signaling have concentrated on the nuclear gene expression response to ^1^O~2~, often relying on the response of a single marker gene ([@bib6]; [@bib10]; [@bib21]; [@bib56]). In contrast, our screen exploited a physiological response to sublethal levels of ^1^O~2~, which induces the wild type to survive a subsequent, otherwise lethal treatment with the ^1^O~2~ generator RB ([@bib35]). The *sak1* mutant completely lacks this ability to acclimate to ^1^O~2~ ([Figure 1A](#fig1){ref-type="fig"}). An analogous phenotype is exhibited by the *yap1Δ* mutant of *Saccharomyces cerevisiae*, which is unable to acclimate to hydrogen peroxide stress ([@bib59]).

In contrast to the complete loss of acclimation to RB, *sak1* acclimates (but less effectively than WT) when pretreated with high light and challenged with RB ([Figure 1B](#fig1){ref-type="fig"}). This result suggests that the high light pretreatment induces a broader response than that elicited by RB and that *sak1* is still able to respond to other signals besides ^1^O~2~ (e.g., plastoquinone redox state, H~2~O~2~, and/or superoxide) that are involved in the response to high light*.* When tested on TAP agar plates for photoheterotrophic growth in the presence of various photosynthetic inhibitors, the *sak1* mutant displayed sensitivity to RB but not to other inhibitors ([Figure 1D](#fig1){ref-type="fig"}). In particular, *sak1* is not more sensitive than WT to high light or norflurazon (an inhibitor of the biosynthesis of carotenoids, which function as quenchers of ^1^O~2~). We speculate that the lack of ^1^O~2~-sensitive phenotype in these plate experiments is attributable to the time-scale of the treatments involved. ^1^O~2~ generated by RB or during a transfer to higher light intensity is transient, whereas NF requires longer time to exert its effect because it needs to enter the cell, inhibit biosynthesis, and deplete cells of existing carotenoids. During this time, the cell is likely able to acclimate by detoxifying and reducing the generation of ^1^O~2~ by various means such as changing the composition of the photosynthetic apparatus. We have previously shown that acclimation to ^1^O~2~ is transient and is dissipated by 24 hr post-treatment ([@bib35]). Consistent with this, pretreatment with RB does not acclimate the cells to stresses such as growth in high light or norflurazon that require a period of days to assess an effect on viability ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We have also observed that under our experimental conditions, the induction of target gene expression upon exposure to ^1^O~2~ lasts up to 90 min and then declines. We conclude that SAK1 functions mainly during transient perturbations that generate ^1^O~2~. However, during steady-state growth under high light or norflurazon, the cell is able to cope by other means that do not involve *SAK1.*

*SAK1* is necessary for a subset of the genome-wide response to ^1^O~2~ in *Chlamydomonas* {#s3-2}
------------------------------------------------------------------------------------------

A physiological acclimation response that results in such an evident growth phenotype ([Figure 1A](#fig1){ref-type="fig"}) likely involves large-scale changes in gene expression, and transcriptome analysis of wild-type cells showed that hundreds of nuclear genes are up- or down-regulated during acclimation to ^1^O~2~ ([Figure 3A,B](#fig3){ref-type="fig"}; [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}, C1). The *sak1* mutant is specifically impaired in regulation of a notable subset of these genes, that is, those that are most strongly induced in the wild type ([Table 5](#tbl5){ref-type="table"}), suggesting that these genes play a key role in the acclimation response to ^1^O~2~.

In particular, many genes involved in sterol and lipid metabolism were induced by ^1^O~2~ in *Chlamydomonas* ([Figure 3B](#fig3){ref-type="fig"}; [Table 3](#tbl3){ref-type="table"}). For example, two genes encoding putative cyclopropane fatty acid synthase (*CFA1* and *CFA2*) exhibited SAK1-dependent induction ([Figure 2](#fig2){ref-type="fig"}). Cyclopropane fatty acids have been found in large amounts in the seeds of *Sterculia foetida* ([@bib5]), although its biological function is unknown. In bacteria, it has been implicated in oxidative stress responses ([@bib26]; [@bib28]) and particularly in the anoxygenic photosynthetic bacterium *Rhodobacter sphaeroides,* CFA gene expression is induced during ^1^O~2~ stress by a σ^E^ factor ([@bib78]). Interestingly CFA mutants of *R. sphaeroides* are compromised in the induction of genes in response to ^1^O~2~, suggesting a regulatory role of the gene, protein, or the product of its enzymatic function (cyclopropane fatty acids, [@bib5]) in gene expression rather than solely a biochemical stress response ([@bib49]).

Another intriguing class of up-regulated genes enriched during ^1^O~2~ acclimation in WT and not in *sak1* was a group of genes encoding transporters, especially ABC transporters related to the MDR and PDR types. This was not surprising considering that ^1^O~2~ exists in aquatic and terrestrial environments, where it is generated by photosensitizing humic substances ([@bib22]; [@bib58]), which are known to affect microbial populations including phytoplankton ([@bib24], [@bib25]). Assuming that some of these transporters function to export photosensitizing molecules from the cell, our results suggest that removal of photosensitizers is an integral part of the ^1^O~2~ response in *Chlamydomonas*, rather than simply a response to the presence of a xenobiotic compound such as RB ([Table 4](#tbl4){ref-type="table"}). It is likely that *Chlamydomonas*, a soil-dwelling microalga, needs to respond to ^1^O~2~ that is generated not only in the chloroplast, but also in other compartments. In this context, it is noteworthy that a recent study has demonstrated light-independent ^1^O~2~ generation in multiple organelles other than the chloroplast under various biotic and abiotic stresses in plants ([@bib47]).

Two proteins with SOUL heme-binding domains were among SAK1-dependent up-regulated genes (SOUL2 and Cre06.g299700.t1.1, formerly annotated as SOUL1 in v4). Aside from their ability to bind various porphyrins ([@bib8]; [@bib54]), SOUL heme-binding proteins have been described in diverse biological functions in mice, such as in apoptosis by interacting with a mitochondrial anti-apoptotic factor Bcl-xL ([@bib1]) or an isoform-specific role in retina and pineal gland ([@bib79]). The latter form is suggested to play a role in transporting heme or by binding free heme to prevent oxidative stress ([@bib54]). In *Arabidopsis* a chloroplast-localized SOUL5 protein has been shown to interact with a heme oxygenase, HY1, and mutation of the gene encoding SOUL5 causes oxidative stress ([@bib36]). *Chlamydomonas* contains five putative SOUL heme-binding proteins, only one of which contains an amino-terminal chloroplast transit peptide. The two SOUL protein genes induced by ^1^O~2~ in our study do not seem to be targeted to the chloroplast, and they may function in the cytosol where SAK1 resides. It would be interesting to test whether these proteins bind porphyrins and are required for ^1^O~2~ acclimation.

A recent study reported the role of bilins in retrograde signaling in *Chlamydomonas* through characterization of heme oxygenase mutants disrupted in bilin biosynthesis and transcriptome analyses during dark to light transitions ([@bib17]). The transcriptome changes indicated that much of the cell's response during a dark-to-light transition (DL) involves photo-oxidative stress. Interestingly, among the 515 genes up-regulated in WT during ^1^O~2~ acclimation, 144 genes overlapped with those that are induced during DL ([Table 9](#tbl9){ref-type="table"}). Focusing on the 104 genes that we defined as SAK1-dependent ([Table 5](#tbl5){ref-type="table"}), 31 genes overlapped ([Table 9](#tbl9){ref-type="table"}). *CFA1*, *CFA2*, and *SOUL2* were among these genes, suggesting that a part of the gene expression response to DL in *Chlamydomonas* is a response to ^1^O~2~. *SAK1* itself was also up-regulated during DL as was *SOR1*, which encodes a more broadly oxidative stress-responsive bZIP transcription factor ([@bib21]). We found that 64 of the genes induced during acclimation to ^1^O~2~ were also up-regulated in the gain-of-function *sor1* mutant ([@bib21]). However, the most strongly induced SAK1-dependent genes were not among these genes, except for *GPX5*, consistent with the idea that *SAK1* and *SOR1* function in different pathways.10.7554/eLife.02286.021Table 9.Genes up-regulated during both ^1^O~2~ acclimation and dark to light transition**DOI:** [http://dx.doi.org/10.7554/eLife.02286.021](10.7554/eLife.02286.021)Gene ID (v4)Gene nameAnnotationRB (log~2~)DL (log~2~) ([@bib17])Cre02.g137700.t1.1[\*](#tblfn20){ref-type="table-fn"}6.492.34Cre06.g281250.t1.1[\*](#tblfn20){ref-type="table-fn"}*CFA1*cyclopropane fatty acid synthase5.924.49Cre01.g033300.t1.1[\*](#tblfn20){ref-type="table-fn"}5.723.62Cre13.g566850.t1.1[\*](#tblfn20){ref-type="table-fn"}*SOUL2*SOUL heme-binding protein5.532.25Cre13.g600650.t1.1[\*](#tblfn20){ref-type="table-fn"}4.763.26Cre06.g263550.t1.1[\*](#tblfn20){ref-type="table-fn"}*LCI7*R53.5-related protein4.465.27Cre07.g342100.t1.1[\*](#tblfn20){ref-type="table-fn"}4.431.84Cre09.g398700.t1.1[\*](#tblfn20){ref-type="table-fn"}*CPLD27*coclaurine N-methyltransferase4.051.36Cre12.g492650.t1.1[\*](#tblfn20){ref-type="table-fn"}*FAS2*fasciclin-like protein4.019.24Cre08.g381510.t1.1[\*](#tblfn20){ref-type="table-fn"}3.943.27Cre10.g458450.t1.2[\*](#tblfn20){ref-type="table-fn"}*GPX5*glutathione peroxidase3.913.08Cre11.g474600.t1.1[\*](#tblfn20){ref-type="table-fn"}3.901.99Cre13.g600700.t1.1[\*](#tblfn20){ref-type="table-fn"}3.785.79Cre14.g613950.t1.1[\*](#tblfn20){ref-type="table-fn"}3.652.68Cre06.g269300.t1.1[\*](#tblfn20){ref-type="table-fn"}3.501.99Cre08.g380300.t1.2[\*](#tblfn20){ref-type="table-fn"}*MSRA3*peptide methionine sulfoxide reductase3.451.79Cre01.g031650.t1.2[\*](#tblfn20){ref-type="table-fn"}*CGLD12*protein with potential galactosyl transferase activity3.304.90Cre14.g629061.t1.1[\*](#tblfn20){ref-type="table-fn"}3.251.88Cre13.g564900.t1.1[\*](#tblfn20){ref-type="table-fn"}3.223.38Cre13.g586450.t1.13.213.50Cre02.g139500.t1.1[\*](#tblfn20){ref-type="table-fn"}3.042.12Cre19.g756100.t1.13.046.53Cre01.g036000.t1.23.021.16Cre14.g618400.t1.1[\*](#tblfn20){ref-type="table-fn"}2.972.16Cre17.g741300.t1.2[\*](#tblfn20){ref-type="table-fn"}2.881.92Cre16.g648700.t1.2[\*](#tblfn20){ref-type="table-fn"}2.792.35Cre17.g729950.t1.12.772.61Cre17.g721000.t1.12.702.12Cre06.g263500.t1.1[\*](#tblfn20){ref-type="table-fn"}2.673.37Cre01.g016150.t1.1[\*](#tblfn20){ref-type="table-fn"}2.652.92Cre08.g380000.t1.1[\*](#tblfn20){ref-type="table-fn"}2.593.74Cre04.g224800.t1.1*VAMP74*R-SNARE protein, VAMP72-family2.583.34Cre03.g210150.t1.12.573.44Cre14.g615600.t1.1[\*](#tblfn20){ref-type="table-fn"}2.532.40Cre06.g293100.t1.1Qc-SNARE SYP6-like protein2.484.90Cre08.g368950.t1.1*DHQS*3-dehydroquinate synthase2.392.49Cre10.g424350.t1.2metalloprotease2.373.18Cre12.g537225.t1.12.343.39Cre07.g336900.t1.22.322.31Cre16.g664050.t1.12.311.88Cre16.g677750.t1.12.042.22Cre12.g537227.t1.12.003.46Cre17.g737050.t1.1RabGAP/TBC protein1.992.32Cre06.g297450.t1.11.931.46Cre06.g258600.t1.1[\*](#tblfn20){ref-type="table-fn"}1.913.63Cre16.g663950.t1.1SC5D, C-5 sterol desaturase1.892.03Cre13.g588150.t1.11.866.21Cre17.g722150.t1.1*PKS3*type III polyketide synthase1.851.61Cre16.g688550.t1.1*GSTS1*glutathione-S-transferase1.841.20Cre03.g207800.t1.11.847.09Cre10.g444550.t1.1[\*](#tblfn20){ref-type="table-fn"}*SPP1A*signal peptide peptidase1.815.33Cre13.g602500.t1.21.761.59Cre03.g163400.t1.2[\*](#tblfn20){ref-type="table-fn"}1.762.15Cre10.g450000.t1.11.742.18Cre01.g015500.t1.11.721.55Cre02.g105750.t1.21.713.23Cre01.g061750.t1.1*SPT2*serine palmitoyltransferase1.712.29Cre83.g796250.t1.11.681.59Cre16.g656150.t1.11.673.55Cre01.g002050.t1.21.663.15Cre12.g556750.t1.2*Tic32-like 1*Short-chain dehydrogenase, classical family, similar to PsTic321.663.15Cre12.g559100.t1.11.663.11Cre09.g411750.t1.21.611.96Cre11.g482650.t1.21.573.40Cre06.g310500.t1.1[\*](#tblfn20){ref-type="table-fn"}1.576.23Cre09.g397900.t1.1transmembrane protein1.562.02Cre04.g215600.t1.11.532.64Cre02.g093800.t1.11.514.99Cre02.g093750.t1.1*NRX2*Nucleoredoxin 21.506.26Cre01.g004350.t1.11.502.29Cre01.g034600.t1.11.502.22Cre11.g472600.t1.21.482.00Cre12.g500500.t1.2*SMT1*sterol-C24-methyltransferase1.463.05Cre13.g577950.t1.1*VPS6*subunit of the ESCRT-III complex1.452.36Cre02.g118200.t1.11.442.79Cre01.g012500.t1.1*PRA1*prenylated rab acceptor family protein1.432.46Cre12.g521600.t1.21.422.89Cre03.g179100.t1.1ubiquitin fusion degradation protein1.413.38Cre09.g413150.t1.21.394.31Cre13.g572200.t1.1tyrosine/tryptophan transporter protein1.392.57Cre03.g185850.t1.2PfkB-type carbohydrate kinase1.373.05Cre18.g743600.t1.11.371.65Cre02.g076800.t1.1sterol reductase1.362.41Cre06.g256750.t1.1*FAT1*acyl carrier protein thioesterase1.351.67Cre17.g729450.t1.11.341.90Cre11.g471550.t1.11.343.29Cre09.g395750.t1.21.332.87Cre14.g617100.t1.11.333.33Cre16.g691500.t1.1Sec14p-like lipid-binding protein1.332.28Cre02.g079550.t1.1*DRP2*Dynamin-related GTPase1.322.34Cre02.g079300.t1.1*VPS4*AAA-ATPase of VPS4/SKD1 family1.321.96Cre05.g231700.t1.21.312.40Cre02.g132300.t1.2*DNJ12*DnaJ-like protein1.302.24Cre69.g794101.t1.11.302.65Cre13.g565600.t1.21.293.42Cre13.g593700.t1.1monooxygenase, DBH-like1.291.81Cre12.g498000.t1.21.283.88Cre06.g292900.t1.21.282.16Cre08.g372100.t1.1*HSP70A*Heat shock protein 7A1.272.28Cre01.g039350.t1.1*NCR2*NADPH-cytochrome P45 reductase1.262.19Cre03.g211100.t1.11.262.11Cre17.g731800.t1.11.251.78Cre17.g730650.t1.11.252.28Cre02.g123000.t1.21.241.42Cre05.g247700.t1.21.242.71Cre08.g360800.t1.2haloacid dehalogenase-like hydrolase1.234.39Cre07.g350750.t1.1*PTOX1*alternative oxidase1.223.32Cre17.g703750.t1.11.202.21Cre06.g306041.t1.11.202.90Cre02.g116650.t1.11.202.83Cre08.g379400.t1.21.183.04Cre16.g677000.t1.1*HSP70E*Heat shock protein 7E1.182.50Cre06.g283900.t1.11.185.24Cre14.g626750.t1.11.174.12Cre01.g010700.t1.11.162.10Cre01.g002000.t1.2predicted proteim1.151.68Cre04.g213150.t1.11.152.78Cre16.g694250.t1.11.152.92Cre05.g246400.t1.11.152.74Cre02.g128450.t1.11.132.82Cre03.g180250.t1.1Myo-inositol-1-phosphate synthase1.132.05Cre03.g186150.t1.11.131.78Cre02.g137800.t1.11.132.00Cre11.g471500.t1.1*MFT10*predicted protein1.111.40Cre10.g435200.t1.11.102.13Cre13.g593850.t1.21.103.91Cre19.g754000.t1.21.102.33Cre13.g593869.t1.11.103.90Cre08.g377300.t1.21.093.27Cre04.g225050.t1.2predicted protein1.093.55Cre07.g330300.t1.11.082.22Cre12.g500450.t1.21.083.00Cre06.g262000.t1.11.081.87Cre10.g441550.t1.2*MAM3B*predicted protein1.071.54Cre06.g249800.t1.1unknown conserved protein1.072.08Cre01.g038250.t1.1*SDC1*serine decarboxylase1.061.92Cre44.g788200.t1.11.062.13Cre08.g359200.t1.21.032.69Cre05.g245950.t1.1*DRP1*Dynamin-related GTPase1.032.15Cre05.g234100.t1.1*CYP745A1*cytochrome P451.012.61Cre07.g328700.t1.21.011.56Cre10.g440250.t1.21.012.14Cre17.g725200.t1.1MDR-like ABC transporter1.013.30Cre82.g796100.t1.11.012.49[^25]

SAK1 is a key intermediate component in the retrograde signaling pathway for ^1^O~2~ acclimation {#s3-3}
------------------------------------------------------------------------------------------------

Cloning of the *SAK1* gene revealed that it encodes a large previously uncharacterized phosphoprotein located primarily in the cytosol ([Figure 6A,D](#fig6){ref-type="fig"}), suggesting that it functions as an intermediate in the retrograde signaling pathway from the chloroplast to the nucleus that leads to ^1^O~2~ acclimation. Previous genetic screens in *Arabidopsis* have identified proteins in the chloroplast, such as EX1 and EX2 ([@bib71]; [@bib37]), and in the nucleus, such as PLEIOTROPIC RESPONSE LOCUS 1 ([@bib7]) and topoisomerase VI ([@bib57]), that are involved in ^1^O~2~ signaling. By screening for mutants that are unable to induce a ^1^O~2~-responsive reporter gene (*HPS70A*) in *Chlamydomonas*, a small zinc finger protein (Cre09.g416500.t1.2) called MBS was recently identified as having a role in ROS signaling in both *Chlamydomonas* and *Arabidopsis* ([@bib56]). Like SAK1, MBS in *Chlamydomonas* is located in the cytosol, raising a question about the relationship of these two proteins in ^1^O~2~ signaling. As expected, we found *HSP70A* among the genes induced by RB treatment of *Chlamydomonas* ([Table 3](#tbl3){ref-type="table"}) however in *sak1* it was not significantly induced above the twofold threshold, suggesting that SAK1 might function in the same signaling pathway as MBS. The *MBS* gene itself is not induced by ^1^O~2~ ([@bib56]), and we will investigate the genetic and biochemical relationship of SAK1 and MBS in future research.

SAK1 contains a novel domain of ∼150 amino acid residues that is found in several chlorophyte species ([Table 8](#tbl8){ref-type="table"}). The sequence of this domain is not highly conserved ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}), and is even less conserved among land plant proteins, although it is detectable by PSI-BLAST, indicating that it has diverged in sequence in plants and algae. We identified 37 proteins that have the SAK1 domain, 13 of which also contained a bZIP transcription factor domain, consistent with a function in regulating gene expression. Under our standard laboratory growth conditions, SAK1 appears to have a relatively low level of phosphorylation, but it becomes hyperphosphorylated during ^1^O~2~ acclimation ([Figure 6D](#fig6){ref-type="fig"}). Phosphorylation prediction software NetPhos 2.0 (<http://www.cbs.dtu.dk/services/NetPhos/>) predicted 24 serine, 9 threonine, and one tyrosine residue as possible sites throughout the protein ([Figure 5---figure supplement 3](#fig5s3){ref-type="fig"}). One of these serine residues is within the conserved SAK1 domain and is relatively conserved for polar amino acids. At this position, 18 SAK1 family members had threonine, and three had serine residues including SAK1 ([Figure 5---figure supplement 1](#fig5s1){ref-type="fig"}). We speculate that phosphorylation of SAK1 in the cytosol is a necessary intermediate step in ^1^O~2~ acclimation. Through further analysis of the transcriptome data, isolation of proteins that physically interact with SAK1, and characterization of additional, non-allelic *sak* mutants, we hope to identify the kinase that is responsible for the direct modification of SAK1 as well as other upstream and downstream components of this retrograde signaling pathway in *Chlamydomonas*.

Material and methods {#s4}
====================

*Chlamydomonas* strains and culture conditions {#s4-1}
----------------------------------------------

The *sak1* mutant was generated by insertional mutagenesis as described previously ([@bib15]) from WT strain 4A+. Cells were grown at 22°C photoheterotrophically in Tris-acetate phosphate media (TAP) unless otherwise stated ([@bib27]).

RB sensitivity screen and acclimation assays {#s4-2}
--------------------------------------------

For systematic screening of large number of strains for increased or decreased resistance to RB, individual strains were inoculated into 180-200 μl TAP medium in 96-well plates, grown for a at least 3 days to saturation under light intensity of 60--80 μmol photons m^−2^ s^−1^, spotted onto TAP plates with 2.7, 3.0, or 3.3 μM RB, and scored for their growth compared to WT and *sak1*. For more quantitative evaluation of RB sensitivity, the cells were grown to saturation in 1 ml of TAP medium because we have observed rapidly growing cells to have more variable sensitivity to RB (data not shown). The cells were counted and adjusted to equal cell density then dispensed into aliquots in duplicate 96-well plates. One of the duplicates was pretreated in dark while the other was placed in light for 40 min with 1 μM RB. For challenge treatments, 4.5, 5.1, 5.7, 6.3, 6.9, and 7.5 μM RB was added to both plates, which were placed under light for 1 hr and then spotted onto TAP agar media with no RB. All treatments were applied under light intensity of 60--80 µmol photons m^−2^ s^−1^, which is the light intensity described as low light unless stated otherwise.

Pretreatment and challenge with RB and F~v~/F~m~ measurement {#s4-3}
------------------------------------------------------------

Cells were grown under 100 μmol photons m^−2^ s^−1^, adjusted to 2 × 10^6^ cells ml^−1^, and treated with RB at a final concentration of 0.5 μM for 30 min (pretreatment) in light (+) or dark (−). After the pretreatment all the cultures were exposed to an additional 3.75 μM RB (challenge) in low light and collected for measurement of F~v~/F~m~ at 30, 60, and 90 min. The cells were dark-acclimated for at least 30 min before applying a saturating light pulse of 2000 μmol photons m^−2^ s^−1^ and measuring the chlorophyll fluorescence yield using an FMS2 fluorometer (Hansatech Instruments, Norfolk, UK).

Culture conditions for gene expression analyses by qRT-PCR and RNA-seq {#s4-4}
----------------------------------------------------------------------

Cultures were grown for at least two light--dark cycles (12 hr light-12 hr dark), and then cell density was adjusted to 2--2.5 × 10^6^ cells ml^−1^ and split into two flasks (one control and the other for RB treatment) at least an hour prior to adding RB to a final concentration of 1 μM. An equal volume of H~2~O was added to the control. RB was added ∼6 hr after the start of the light cycle under light intensity of ∼100 µmol photons m^−2^ s^−1^ and the treatment lasted for an hour before harvest. The cells were cooled and harvested by centrifugation at 1200×*g* for 3 min at 4°C, frozen with liquid nitrogen and stored at −80°C until extraction of RNA. For low light to high light transfer experiment, cultures were grown in continuous light in minimal (HS) medium for 3 days to cell density of 3 × 10^6^ cells ml^−1^ at 45 µmol photons m^−2^ s^−1^. The light intensity was increased to 500 µmol photons m^−2^ s^−1^ for 1 hr before harvest.

Gene expression analysis by qRT-PCR {#s4-5}
-----------------------------------

RNA was extracted with TRIzol (Life Technologies, Carlsbad, CA) following manufacturer\'s instructions and treated with DNaseI (Promega, Madison, WI), then cleaned up using Qiagen RNeasy columns (Qiagen, Germantown, MD). cDNA was synthesized using Omniscript (Qiagen, Germantown, MD) starting with 2--3 μg DNA-free RNA per 20 μl reaction. qPCR was performed using a 7300 FAST qPCR machine (Life Technologies, Carlsbad, CA). The primers were designed with a T~m~ of 60°C using Primer3 or PrimerExpress (Life Technologies, Carlsbad, CA) ([Table 10](#tbl10){ref-type="table"}). All primer pairs described in this study were confirmed as having 90--105% amplification efficiency and linear amplification within their dynamic range in experimental samples using serial dilutions of cDNA prior to the experiments. Relative transcript levels were calculated by ΔΔCt method ([@bib41]) using *CβLP* as internal reference.10.7554/eLife.02286.022Table 10.Primers used for qRT-PCR analyses**DOI:** [http://dx.doi.org/10.7554/eLife.02286.022](10.7554/eLife.02286.022)v4 IDv5 IDGene nameForwardReverseCre01.g007300.t1.1Cre01.g007300.t1.2AGCATGTGCGTGTGGAGTAGCCTTACCATAGGCCTGACCAau5.g10700_t1aCre03.g177600.t1.3CTGGACATGTCGGCTATGAAGCTCATGTCGTACTCCAGCAau5.g13389_t1[\*](#tblfn21){ref-type="table-fn"}Cre06.g299700.t1*SOUL1*[†](#tblfn22){ref-type="table-fn"}TGCGTATGGGTGTCCACTAATGGGGATCTTCTTCATGTCCCre06.g263550.t1.1Cre06.g263550.t1.2*LCI7*TTTGGTTGCGTTGCATGTATTCAACGCGGTGTCAAACTTACre06.g281250.t1.1Cre06.g281250.t1.2*CFA1*CCTACAACGACAACGACGTGGGAAGTTCCAGGATGACCAGCre06.g298750.t1.1Cre06.g298750.t1.2*AOT4*CCGTGTGCACAGATTCAAAGCACACAGCGCCTCCTACATACre08.g358200.t1.2Cre08.g358200.t2.1TGTGGCATCAAGGTGTGTTGTAACCCCACACCCCTCTCTTTCre09.g398700.t1.1Cre09.g398700.t1.2*CFA2*CGACCTGCTGCTCTACTTCCGTGTAGGCGGTGGTCAAGATCre10.g458450.t1.2Cre10.g458450.t1.3*GPX5*AACCAATCGCCTAACACCTGCACTTGCTAGCCACGTTCACCre12.g503950.t1.1Cre12.g503950.t1.2GGAGGGAGTACCACGAGACAGATTGCTGTAAGGCCGGATACre13.g564900.t1.1Cre13.g564900.t1.2*MRP3*TCATGACGTACATCTCGATTCTCAAGGGAATGTAGTAGCGCTGAATGau5.g4402_t1[\*](#tblfn21){ref-type="table-fn"}Cre13.g566800.t1.2TGCTTGGAAGACCCACTTTTGAGCTGGAGTTGCAGTTGTGCre13.g566850.t1.1Cre13.g566850.t1.2*SOUL2*CCCTCCCCTCCTTCAGACTACGTACCTGAGGCGCATATTTCre14.g613950.t1.1Cre14.g613950.t2.1CGCCCAACCCCATGATCCCGCAACGTACCGTGATGCre16.g683400.t1.1Cre16.g683400.t1.2CCTGAACAAACACACGATGGGAACGCCGTCAAATCATCTTCre16.g688550.t1.1Cre16.g688550.t1.2*GST1*AGTGCGGAGGAAGTCGTAAAGTAAAAGACGTGCGTGCAAAg6364.t1*CβLP(RCK1)*GAGTCCAACTACGGCTACGCGGTGTTCAGGTCCCACAGACCre14.g623650.t1.1Cre14.g623650.t1GACAACGCGGCCTACAAGACCGAGCTGGCGGTGTTAAau5.g2281_t1[\*](#tblfn21){ref-type="table-fn"}g16723.t1*MKS1*GCTTGAGCGCGAGACGAACGCTGAAAGCATTGCAGAAGCre08.g380300.t1.2Cre08.g380300.t1.2ACCACCAGCAGTACCTGTCCCGCTCCAATAAAGCCTTCAGau5.g7871_t1[‡](#tblfn23){ref-type="table-fn"}(Cre17.g741300.t1.2)[‡](#tblfn23){ref-type="table-fn"}*SAK1(5\'UTR)*CAAGTGCTCATGAGAGGCCTTATACGTCATCCAGTTCCACATCCau5.g7871_t1[‡](#tblfn23){ref-type="table-fn"}(Cre17.g741300.t1.2)[‡](#tblfn23){ref-type="table-fn"}*SAK1(3\'UTR)*TCAAGCGTGTGGGTAAGAGCTAACGCTATCTCCGTCCTAATCCACre08.g365900.t1.1Cre08.g365900.t1.2*LHCSR1*CACACAATTCTGCCAACAGCATCTGCTTCACGGTTTGGTCCre04.g220850.t1.1Cre04.g220850.t1.2TAATGGTATGGATGCGGTCAACTGCCAGTTATGGGTCCTGCre09.g395750.t1.2Cre09.g395750.t1.3ACCGTCCGTGAACCTTACTGCGCAAACACGTCTCAAAGAA[^26][^27][^28]

RNA-seq library preparation and analysis {#s4-6}
----------------------------------------

RNA was extracted ([@bib55]) and the quality was determined using a 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). The triplicate RNA was pooled and 10 μg total RNA was used to prepare RNA-seq library according to the manufacturer\'s protocol (Illumina, San Diego, CA). The quality of the library was assessed using a 2100 Bioanalyzer before sequencing with Genome Analyzer (Illumina, San Diego, CA). Each sample was run in replicates on two lanes. RNA-Seq data was analyzed as before ([@bib17]). On average, 75% of the sequences could be assigned unambiguously to Augustus v10.2 gene models to generate the matrix of counts per gene. This matrix was used for differential expression analysis using *DESeq* ([@bib2]) using *per-condition* dispersion estimates and variance stabilization to compute moderate fold changes. Genes were classified as differentially expressed based on a (moderate) twofold regulation and a false discovery rate (FDR) \<1%.

Amplification of cDNA and genomic region of *SAK1* and transformation of *sak1* {#s4-7}
-------------------------------------------------------------------------------

Near full-length cDNA was isolated by RT-PCR (described in above section; Gene expression analysis by qRT-PCR) and rapid amplification of cDNA ends (RACE) using GeneRACER (Life Technologies, Carlsbad, CA) as previously described ([@bib46]). Despite multiple attempts the 5′ end of the transcript could not be amplified by 5′-RACE. Because the experimentally obtained CDS differed from the most current v5, it has been deposited to genbank (accession KF985242). Though some differences exist at the nucleotide level, the protein sequence of the resulting CDS was identical to that of au5.g7871_t1. Genomic DNA containing *SAK1* was amplified using primers 5′-CAGGACCGGGCACTGAGTGAAGGTTA-3′ (+) and 5′-ATGATGCACTGTGGGACACGCTGAGT-3′ (−) using PrimeStar HS with GC buffer (Takara/Clontech, Palo Alto, CA) and cloned into pGEM-Teasy after adding an adenine. The resulting plasmid was co-transformed with pBC1 and selected with 1 μM paromomycin. Transformation of *sak1* was performed as described previously ([@bib29]).

SAK1 antibody generation and protein detection by immunoblotting {#s4-8}
----------------------------------------------------------------

To raise antibodies against SAK1, an epitope at the N-terminus of the translated coding sequence of SAK1 (DTLLTPLREDATAESGGDA) was designed, synthesized and injected into rabbits, and the resulting crude serum was affinity purified (Open Biosystems/Thermo Scientific, Waltham, MA). For immunoblot detection of SAK1, proteins were separated with NuPAGE 3--8% Tris Acetate gels (Life Technologies, Carlsbad, CA) and transferred to nitrocellulose membranes. All other blots were prepared from running the protein on 10--20% Tris-glycine gels and transferring to a PVDF membrane. The membranes were blocked for several hours in 5% milk in TBS-T, incubated with the primary antibody overnight, then with secondary antibody for several hours in 1% milk TBS-T before washing and developing with a chemiluminescence detection kit. Commercial antibodies were anti-histone H3 (ab1791; Abcam, Cambridge, UK) and anti-KDEL (ab12223; Abcam, Cambridge, UK). Other antibodies were generous gifts from Jean-David Rochaix (anti-PSAD), Olaf Kruse (anti-NAB1), and Patrice Hamel (anti-cytochrome *c*).

Subcellular fractionation and protein quantification {#s4-9}
----------------------------------------------------

Nuclear fractions were prepared from 450 ml of synchronized cultures with ∼2 × 10^6^ cells ml^−1^ that had been incubated with or without 2 μM RB under light for 40 min. The cells were collected and treated with autolysin for 40 min and examined for the removal of cell walls by addition of 1 volume of 0.1% Triton-X. Nuclear extract was prepared as described previously ([@bib74]) using CelLytic PN kit (Sigma-Aldrich, St. Louis, MO). Because there were bands detected in the nuclear extract close to the size of SAK1, nuclear extract was prepared from WT (4A+) and *sak1* rather than a cell wall-deficient strain (*cw15*). Chloroplasts were isolated from cell wall-less strain *cw15* as described previously ([@bib30]). Mitochondria were isolated as described ([@bib18]). After unbroken cells, chloroplasts, and mitochondria were collected, the ER fraction was collected by centrifugation at 100,000×*g* for 90 min at 4°C. The remaining supernatant was enriched for cytosol. Protein was extracted and prepared for SDS-PAGE as described ([@bib11]) with minor modifications. Protein was quantified by using BCA1 kit (Sigma-Aldrich, St. Louis, MO) after extraction with the methanol-chloroform method ([@bib73]).
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Genes that display significant differential expression by pair-wise comparisons.

**DOI:** [http://dx.doi.org/10.7554/eLife.02286.023](10.7554/eLife.02286.023)

Major dataset
-------------

The following dataset was generated:

WakaoS, ChinBL, LedfordHK, DentRM, CaseroD, PellegriniM, MerchantSS, NiyogiKK, 2014,Data from: Phosphoprotein SAK1 is a regulator of acclimation to singlet oxygen in Chlamydomonas reinhardtii,[http://dx.doi.org/doi:10.5061/dryad.h7pm2](http://dx.doi.org/10.5061/dryad.h7pm2),Available at Dryad Digital Repository under a CC0 Public Domain Dedication.
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eLife posts the editorial decision letter and author response on a selection of the published articles (subject to the approval of the authors). An edited version of the letter sent to the authors after peer review is shown, indicating the substantive concerns or comments; minor concerns are not usually shown. Reviewers have the opportunity to discuss the decision before the letter is sent (see [review process](http://elifesciences.org/review-process)). Similarly, the author response typically shows only responses to the major concerns raised by the reviewers.

Thank you for sending your work entitled "Phosphoprotein SAK1 is a regulator of acclimation to singlet oxygen in *Chlamydomonas reinhardtii*" for consideration at *eLife*. Your article has been favorably evaluated by a Senior editor, Detlef Weigel, and 2 reviewers, one of whom, Todd Mockler, is a member of our Board of Reviewing Editors.

The Reviewing editor and the other reviewer discussed their comments before we reached this decision, and the Reviewing editor has assembled the following comments to help you prepare a revised submission.

This manuscript from Wakao et al addresses SAK1, a cytoplasmic phosphoprotein that is a component of the retrograde signaling pathway between the plastid and nucleus. SAK1 functions in regulation of nuclear gene expression during acclimation of Chlamydomonas cells to reactive oxygen species (ROS). This is an interesting and timely manuscript on an interesting topic. While ROS are implicated in pathologies including stresses, signal transduction, and developmental regulation in multiple systems, ROS signaling pathways remain to be elucidated in detail. Singlet oxygen (1O2) is a particularly toxic form of ROS that is generated during photosynthesis. Plants and algae have evolved retrograde signaling between the chloroplast and the nucleus through which singlet oxygen species modulate nuclear gene expression and acclimation to oxidative stress. Specifically relevant to this manuscript, few components of singlet oxygen signaling have been discovered in any system, and there remains a large gap between singlet oxygen generation in the chloroplast and mediation of gene expression regulation in the nucleus.

This work concerns the characterization of a *Chlamydomonas* mutant called *sak1* that is unable to increase its tolerance to singlet oxygen. SAK1 is a novel cytosolic phosphoprotein containing a domain that is conserved among some bZIP transcription factors. SAK1 accumulation is itself induced and phosphorylated upon exposure to singlet oxygen, consistent with its function in the retrograde signal transduction pathway(s) leading to acclimation to singlet oxygen stress. Gene responses to RB are shown to be substantially affected in the *sak1* mutant. The protein encoded by SAK1 is shown to be located in the cytosol and phosphorylated upon exposure of the microalgal cells to RB. The experiments seem to have been done carefully and the manuscript is written in a clear and concise manner.

In summary, this is a well-written manuscript that presents a new protein, identified in a clever mutant screen that is implicated in both retrograde signaling and ROS response. This factor is of general interest due to its relevance to photosynthesis and primary metabolism, retrograde signaling, ROS, and abiotic stress responses.

Specific concerns to be addressed in the revised manuscript and response to the reviews are as follows:

1\) Are the data presented here really representative of the response of photosynthetic organisms to natural conditions of 1O2 stress, e.g. excess light energy? In [Figure 1A](#fig1){ref-type="fig"}, it is shown that RB-pretreated WT cells become resistant to high concentrations of RB. However, it is not shown whether or not RB-treated cells are also resistant to high light or Norflurazon, two conditions known to produce 1O2 in the chloroplasts. These data should be shown in the manuscript to demonstrate that the acclimation mechanism described here can be extrapolated to natural 1O2 stress conditions.

2\) Did the authors compare the RB-induced changes in gene expression with the gene expression profile in high light-exposed Chlamydomonas cells?

3\) Intriguingly, the *sak1* mutant grows in high light similarly to the WT strain, and it is not more sensitive to Norflurazon compared to WT ([Figure 1B](#fig1){ref-type="fig"}). This suggests that the sak1 mutation does not affect the response to 1O2 when it is produced in the chloroplast. Is this absence of phenotype of the *sak1* mutant also observed when the HL and Norflurazon treatments were imposed after acclimation to RB?

4\) During acclimation of WT to RB, genes involved in transport constitute one of the most enriched classes ([Table 3](#tbl3){ref-type="table"}). The authors interpret this striking effect as a response of the cells to pump RB out, reinforcing the idea that at least part of the changes in gene expression is a response to RB itself rather than a response to singlet oxygen. In this context, it would be useful to compare the expression of the genes shown in [Figure 2](#fig2){ref-type="fig"} when RB is imposed in the dark (no 1O2 produced) or in the light.

5\) The authors should pay more attention to the physiological meaning of the treatments that they used to isolate and characterize their mutant. A few additional experiments could be helpful to convince the readers that the gene responses described in this manuscript can be useful to understand the responses of photosynthetic organisms to 1O2 produced in vivo under excess light energy.

6\) Are [Figure 2](#fig2){ref-type="fig"} and [Table 1](#tbl1){ref-type="table"} redundant? They seem to present the same data and of the two, [Table 1](#tbl1){ref-type="table"} is more complete because it presents both the RNA-seq and qRT-PCR results. The standard deviations could be added to [Table 1](#tbl1){ref-type="table"} and would make [Figure 2](#fig2){ref-type="fig"} unnecessary.

10.7554/eLife.02286.025

Author response

*1) Are the data presented here really representative of the response of photosynthetic organisms to natural conditions of 1O2 stress, e.g. excess light energy? In* [*Figure 1A*](#fig1){ref-type="fig"}*, it is shown that RB-pretreated WT cells become resistant to high concentrations of RB. However, it is not shown whether or not RB-treated cells are also resistant to high light or Norflurazon, two conditions known to produce 1O2 in the chloroplasts. These data should be shown in the manuscript to demonstrate that the acclimation mechanism described here can be extrapolated to natural 1O2 stress conditions*.

We have published previously that WT Chlamydomonas can acclimate to RB following pretreatment with high light ([@bib35]), indicating that 1O2 generation by excess light elicits a response overlapping with the response to RB. We have repeated this experiment including sak1, and the results in new [Figure 1B](#fig1){ref-type="fig"} show that the mutant acclimates less effectively. The mutant does exhibit some acclimation, however, which we attribute to the fact that high light initiates several signaling pathways in addition to 1O2 (e.g. reduced PQ pool, H2O2, O2-), to which sak1 is still capable of responding, and we have previously shown that a more general oxidative stress response can induce resistance to RB ([@bib21]).

On the other hand, pretreatment with RB did not increase resistance to HL or norflurazon in WT or sak1 (new [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}). Acclimation to 1O2 is transient, lasting less than 24 hours ([@bib35]), and SAK1 appears to be involved in the early and transient response to 1O2 during perturbations rather than actively detoxifying during long-term, chronic stresses, as can be seen in the wild-type growth of sak1 on medium containing norflurazon or in HL ([Figure 1D](#fig1){ref-type="fig"} in the revised [Figure 1](#fig1){ref-type="fig"}). We speculate that over the days required to see growth in HL or norflurazon, the cells are able to adjust their physiology in different ways to reduce 1O2 generation and/or toxicity.

*2) Did the authors compare the RB-induced changes in gene expression with the gene expression profile in high light-exposed* Chlamydomonas *cells?*

We have tested the expression of several of the 1O2-responsive genes (new [Table 1](#tbl1){ref-type="table"}) and the SAK1 transcript (new [Figure 4G](#fig4){ref-type="fig"}) during a low to high light transition and found that they are moderately induced compared to induction by RB. This was expected because 1O2 is a part of the high light response, whereas RB treatment isolates and amplifies the 1O2-dependent part of this response.

*3) Intriguingly, the sak1 mutant grows in high light similarly to the WT strain, and it is not more sensitive to Norflurazon compared to WT (*[*Figure 1B*](#fig1){ref-type="fig"}*). This suggests that the* sak1 *mutation does not affect the response to 1O2 when it is produced in the chloroplast*. *Is this absence of phenotype of the sak1 mutant also observed when the HL and Norflurazon treatments were imposed after acclimation to RB?*

Please see our responses to points 1 and 2 above. High light is known to induce 1O2 production in the chloroplast, so our observation of impaired RB acclimation in sak1 after pretreatment with high light (new [Figure 1B](#fig1){ref-type="fig"}) suggests that sak1 does indeed affect the response to 1O2 produced in the chloroplast. As described above, the acclimation induced by RB pretreatment is transient ([@bib35]) and thus presumably is not maintained long enough to confer resistance to chronic high light or norflurazon stress.

*4) During acclimation of WT to RB, genes involved in transport constitute one of the most enriched classes (*[*Table 3*](#tbl3){ref-type="table"}*). The authors interpret this striking effect as a response of the cells to pump RB out, reinforcing the idea that at least part of the changes in gene expression is a response to RB itself rather than a response to singlet oxygen. In this context, it would be useful to compare the expression of the genes shown in* [*Figure 2*](#fig2){ref-type="fig"} *when RB is imposed in the dark (no 1O2 produced) or in the light*.

We examined this issue by performing an additional experiment comparing gene expression in the dark with or without RB (new [Table 4](#tbl4){ref-type="table"}), and we found that the expression levels of the 1O2 target genes (including specific ABC transporter genes) remained unchanged when cells were exposed to RB in the dark. This result demonstrates that the induction of these genes is due to 1O2 rather than RB itself. The RB-dark vs. RB-light comparison strongly resembled that of mock-light vs. RB-light and did not directly address whether the some of the genes were responding to the chemical RB or 1O2. Besides being produced by excess light, 1O2 is known to be generated by naturally occurring photosensitizers (e.g. humic substances) in aquatic and terrestrial environments. Microbes and phytoplankton must respond to this stress, and our results are relevant to understanding how this occurs. We have added text and references to clarify and discuss these topics.

*5) The authors should pay more attention to the physiological meaning of the treatments that they used to isolate and characterize their mutant. A few additional experiments could be helpful to convince the readers that the gene responses described in this manuscript can be useful to understand the responses of photosynthetic organisms to 1O2 produced in vivo under excess light energy*.

In addition to the cross-acclimation experiments (new [Figure 1B](#fig1){ref-type="fig"} and new [Figure 1--figure supplement 1](#fig1s1){ref-type="fig"}), we performed an experiment to measure Fv/Fm (maximum efficiency of photosystem II) during RB treatments (new [Figure 1C](#fig1){ref-type="fig"}). The data show that 1O2 generated during RB treatment causes inhibition of photosystem II in the chloroplast and that pretreatment alleviates this inhibition, consistent with the growth phenotype seen in [Figure 1A](#fig1){ref-type="fig"}.

*6) Are* [*Figure 2*](#fig2){ref-type="fig"} *and* [*Table 1*](#tbl1){ref-type="table"} *redundant? They seem to present the same data and of the two,* [*Table 1*](#tbl1){ref-type="table"} *is more complete because it presents both the RNA-seq and qRT-PCR results. The standard deviations could be added to* [*Table 1*](#tbl1){ref-type="table"} *and would make* [*Figure 2*](#fig2){ref-type="fig"} *unnecessary*.

As described in the Material and methods, our RNA-seq was performed with a single, pooled RNA-seq library prepared from biological triplicates. Therefore we feel it is important to validate the expression profiles of at least some of the genes. [Figure 2](#fig2){ref-type="fig"} has extra information compared to the Table on the basal level of expression in the mutant compared to WT rather than only fold change; some genes are already elevated in the sak1 mutant without RB, suggesting that the mutant is experiencing some constitutive stress. We therefore would like to keep [Figure 2](#fig2){ref-type="fig"} as is and have moved the original [Table 1](#tbl1){ref-type="table"} that compares fold changes calculated from RNA-seq and qPCR to accompany [Figure 2](#fig2){ref-type="fig"} and renamed it [Figure 2](#fig2){ref-type="fig"}.

[^1]: Department of Systems Biology, Harvard Medical School, Boston, United States.

[^2]: Nature News, Nature Publishing Group, Cambridge, United States.

[^3]: School of Public Health, Univeristy of California, Berkeley, Berkeley, United States.

[^4]: Department of Pathology and Laboratory Medicine, University of California, Los Angeles, Los Angeles, United States.

[^5]: Fold change values are the average of biological triplicates and their standard deviations are indicated in parentheses.

[^6]: Known to have elevated expression in high light grown cells ([@bib52]).

[^7]: Average of RPKM obtained from two sequencing lanes as described in 'Material and methods'.

[^8]: Calculated as ratio of (RPKM-RB) / (RPKM-mock).

[^9]: Functional terms are inferred by homology to the annotation set of *Arabidopsis thaliana* ([@bib42]).

[^10]: Corresponding gene model was not found in v5.

[^11]: No functional annotations found on v5 but defined by MapMan on Algal Functional Annotation Tool ([@bib42]).

[^12]: Induction during ^1^O~2~ acclimation dependent on SAK1 ([Table 5](#tbl5){ref-type="table"}).

[^13]: Average of fold change and standard deviation (SD) of biological triplicates.

[^14]: Annotated as transport function.

[^15]: ABC transporter.

[^16]: Sec14-like phosphatidylinositol transfer protein.

[^17]: Data were ordered by FC in WT.

[^18]: Of the 52 most highly induced genes in WT (the top 10%), 37 were SAK1-dependent, and the induction of 33 of these genes was strongly attenuated to only 0.01-0.25 of magnitude of FC found in the WT. Dashed line indicates cutoff of FC for the top 10% most strongly induced genes.

[^19]: Genes that are repressed at basal level in *sak1.*

[^20]: NF, not found in v5.

[^21]: Corresponding gene model was not found in v5.

[^22]: Functional terms are inferred by homology to the annotation set of *Arabidopsis thaliana* ([@bib42]).

[^23]: Corresponding gene model was not found in v5.

[^24]: 1--25, as defined on phytozome.net; 26--37, CrSAK1, genbank accession numbers.

[^25]: Genes defined as SAK1-dependent in [Table 4](#tbl4){ref-type="table"}.

[^26]: Was originally mapped and identified as augustus version 5 models within *Chlamydomonas* genome v4.

[^27]: *SOUL1* was given the name in v4 but not v5.

[^28]: Primers were designed against experimentally obtained cDNA (Genbank accession KF985242) and differs from v5. Closest gene model is au5.g7871_t1.
